1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
X Quarterly report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
For the quarterly period ended September 30, 1994
or
Transition report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
For the transition period from to
Commission File Number 1-87
EASTMAN KODAK COMPANY
(Exact name of registrant as specified in its charter)
NEW JERSEY 16-0417150
(State of incorporation) (IRS Employer
Identification No.)
343 STATE STREET, ROCHESTER, NEW YORK 14650
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 716-724-4000
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months, and (2) has been subject to such filing
requirements for the past 90 days.
Yes X No
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
Number of Shares Outstanding at
Class September 30, 1994
Common Stock, $2.50 par value 339,685,483
2
Eastman Kodak Company and Subsidiary Companies
CONSOLIDATED STATEMENT OF EARNINGS
(in millions) Third Quarter Three Quarters
1994 1993 1994 1993
REVENUES
Sales $3,529 $3,160 $9,709 $ 9,181
Earnings from equity interests and other
revenues 2 27 70 156
------ ------ ------ -------
TOTAL REVENUES 3,531 3,187 9,779 9,337
------ ------ ------ -------
COSTS
Cost of goods sold 1,967 1,625 5,219 4,688
Marketing and administrative expenses 972 829 2,644 2,499
Research and development costs 221 231 655 648
Interest expense 28 41 113 145
Restructuring costs - 495 - 495
Other charges 25 41 133 122
------ ------ ------ -------
TOTAL COSTS 3,213 3,262 8,764 8,597
------ ------ ------ -------
Earnings (loss) from continuing operations
before income taxes 318 (75) 1,015 740
Provision (benefit) for income taxes from
continuing operations 125 (1) 382 316
------ ------ ------ -------
Earnings (loss) from continuing operations
before extraordinary item and cumulative
effect of changes in accounting principle 193 (74) 633 424
Earnings (loss) from discontinued operations
before cumulative effect of changes in
accounting principle - 7 (81) 41
------ ------ ------ -------
Earnings (loss) before extraordinary item and
cumulative effect of changes
in accounting principle 193 (67) 552 465
Extraordinary item - (1) (13) (13)
------ ------ ------ -------
Earnings (loss) before cumulative effect of
changes in accounting principle 193 (68) 539 452
------ ------ ------ -------
Cumulative effect of changes in accounting
principle from continuing operations - - - (1,649)
Cumulative effect of changes in accounting
principle from discontinued operations - - - (519)
------ ------ ------ -------
Total cumulative effect of changes in
accounting principle - - - (2,168)
------ ------ ------ -------
NET EARNINGS (LOSS) $ 193 $ (68) $ 539 $(1,716)
====== ====== ====== =======
- - -----------------------------------------------------------------------------
See Notes to Financial Statements
3
Eastman Kodak Company and Subsidiary Companies
CONSOLIDATED STATEMENT OF EARNINGS (Continued)
Third Quarter Three Quarters
1994 1993 1994 1993
Primary earnings (loss) per share from
continuing operations before extraordinary
item and cumulative effect of changes in
accounting principle $ .57 $ (.23) $ 1.89 $ 1.29
Primary earnings (loss) per share from
discontinued operations before cumulative
effect of changes in accounting principle - .02 (.24) .13
------ ------ ------ ------
Primary earnings (loss) per share before
extraordinary item and cumulative effect of
changes in accounting principle .57 (.21) 1.65 1.42
Extraordinary item - - (.04) (.04)
------ ------ ------ ------
Primary earnings (loss) per share before
cumulative effect of changes in
accounting principle .57 (.21) 1.61 1.38
------ ------ ------ ------
Cumulative effect of changes in accounting
principle from continuing operations - - - (5.04)
Cumulative effect of changes in accounting
principle from discontinued operations - - - (1.58)
------ ------ ------ ------
Total cumulative effect of changes in
accounting principle - - - (6.62)
------ ------ ------ ------
Primary earnings (loss) per share $ .57 $ (.21) $ 1.61 $(5.24)
====== ====== ====== ======
Fully diluted earnings (loss) per share from
continuing operations before extraordinary
item and cumulative effect of changes in
accounting principle $ .56 $ (.17) $ 1.86 $ 1.29
Fully diluted earnings (loss) per share from
discontinued operations before cumulative
effect of changes in accounting principle - .02 (.24) .12
------ ------ ------ ------
Fully diluted earnings (loss) per share before
extraordinary item and cumulative effect of
changes in accounting principle .56 (.15) 1.62 1.41
Extraordinary item - - (.04) (.03)
------ ------ ------ ------
Fully diluted earnings (loss) per share before
cumulative effect of changes in
accounting principle .56 (.15) 1.58 1.38
------ ------ ------ ------
Cumulative effect of changes in accounting
principle from continuing operations - - - (5.04)
Cumulative effect of changes in accounting
principle from discontinued operations - - - (1.58)
------ ------ ------ ------
Total cumulative effect of changes in
accounting principle - - - (6.62)
------ ------ ------ ------
Fully diluted earnings (loss) per share $ .56 $ (.15) $ 1.58 $(5.24)
====== ====== ====== ======
- - -----------------------------------------------------------------------------
See Notes to Financial Statements
4
CONSOLIDATED STATEMENT OF RETAINED EARNINGS
Third Quarter Three Quarters
(in millions) 1994 1993 1994 1993
RETAINED EARNINGS
Retained earnings at beginning of period $4,552 $5,746 $4,469 $7,721
Net earnings (loss) 193 (68) 539 (1,716)
Cash dividends declared (136) (165) (401) (492)
Other changes (3) - (1) -
------ ------ ------ ------
RETAINED EARNINGS at end of period $4,606 $5,513 $4,606 $5,513
====== ====== ====== ======
- - --------------------------------------------------------------------------------------
SUPPLEMENTAL INFORMATION:
Operations of subsidiary companies outside
the U.S. included in Consolidated Statement
of Earnings:
Sales $2,070 $1,869 $5,741 $5,434
Earnings from operations 143 57 436 295
- - ----------------------------------------------------------------------------------
See Notes to Financial Statements
5
Eastman Kodak Company and Subsidiary Companies
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
Sept. 30, Dec. 31,
(in millions) 1994 1993
ASSETS
CURRENT ASSETS
Cash and cash equivalents $ 585 $ 1,635
Marketable securities 142 331
Receivables (net of allowances of $108 and $92) 3,148 2,817
Inventories 1,765 1,532
Deferred income tax charges 457 339
Other 392 203
------- -------
Total current assets 6,489 6,857
------- -------
PROPERTIES
Land, buildings and equipment at cost 12,429 11,601
Less: Accumulated depreciation 7,003 6,574
------- -------
Net properties 5,426 5,027
------- -------
OTHER ASSETS
Unamortized goodwill (net of accumulated
amortization of $210 and $179) 673 272
Long-term receivables and other
noncurrent assets 782 912
Deferred income tax charges 352 393
Net assets of discontinued operations 5,361 5,349
------- -------
TOTAL ASSETS $19,083 $18,810
======= =======
- - --------------------------------------------------------------------------
LIABILITIES AND SHAREOWNERS' EQUITY
CURRENT LIABILITIES
Payables $ 3,025 $ 2,877
Short-term borrowings 2,460 611
Taxes-income and other 415 384
Dividends payable 136 165
Deferred income tax credits 46 16
------- -------
Total current liabilities 6,082 4,053
OTHER LIABILITIES AND DEFERRED CREDITS
Long-term borrowings 4,667 6,727
Postemployment liabilities 3,603 3,491
Other long-term liabilities 621 1,183
Deferred income tax credits 50 -
------- -------
Total liabilities 15,023 15,454
------- -------
SHAREOWNERS' EQUITY
Common stock at par* 966 948
Additional capital paid in or
transferred from retained earnings 510 213
Retained earnings 4,606 4,469
Accumulated translation adjustment (66) (235)
------- -------
6,016 5,395
Less: Treasury stock shares at cost* 1,956 2,039
------- -------
Total shareowners' equity 4,060 3,356
------- -------
TOTAL LIABILITIES AND SHAREOWNERS' EQUITY $19,083 $18,810
======= =======
* Common stock: $2.50 par value, 950 million shares authorized, 386 million
shares issued as of September 30, 1994. Treasury stock at cost consists of
approximately 49 million shares on December 31, 1993 and approximately 47
million shares on September 30, 1994.
- - -------------------------------------------------------------------------
See Notes to Financial Statements
6
Eastman Kodak Company and Subsidiary Companies
CONSOLIDATED STATEMENT OF CASH FLOWS
Three Quarters
(in millions) 1994 1993
Cash flows from operating activities:
Earnings from continuing operations before
extraordinary item and cumulative effect of
changes in accounting principle $ 633 $ 424
Adjustments to reconcile above earnings to net cash
provided by operating activities:
Depreciation and amortization 613 639
Benefit for deferred taxes (8) (38)
Loss on sale and retirement of properties 38 102
Increase in receivables (128) (57)
Increase in inventories (131) (115)
Increase in liabilities excluding borrowings 77 322
Other items, net (244) (53)
------ ------
Total adjustments 217 800
------ ------
Net cash provided by operating activities 850 1,224
------ ------
Cash flows from investing activities:
Additions to properties (814) (612)
Proceeds from sale of investments - 43
Proceeds from sale of properties 41 5
Marketable securities - sales 242 1
Marketable securities - purchases (27) -
Payment for purchase of Qualex, net of
cash acquired (48) -
------ ------
Net cash used in investing activities (606) (563)
------ ------
Cash flows from financing activities:
Net increase in commercial paper borrowings
of 90 days or less 1,385 (255)
Proceeds from other borrowings 2 544
Repayment of other borrowings (1,483) (536)
Unwinding of derivatives (814) -
Dividends to shareowners (429) (492)
Exercise of employee stock options 29 166
------ ------
Net cash used in financing activities (1,310) (573)
------ ------
Effect of exchange rate changes on cash 16 (2)
------ ------
Net increase (decrease) in cash and cash equivalents (1,050) 86
Cash and cash equivalents, beginning of year 1,635 361
------ ------
Cash and cash equivalents, end of period $ 585 $ 447
====== ======
- - --------------------------------------------------------------------------
See Notes to Financial Statements
7
NOTES TO FINANCIAL STATEMENTS
BASIS OF PRESENTATION
The financial statements have been prepared by the Company in accordance with
the accounting policies stated in the 1993 Annual Report, except as noted
below, and should be read in conjunction with the Notes to Financial
Statements appearing therein. In the opinion of the Company, all adjustments
(consisting only of normal recurring adjustments) necessary for a fair
presentation have been included in the financial statements. The statements
are based in part on approximations and have not been audited by independent
accountants. The annual statements will be audited by Price Waterhouse.
FAIR VALUES OF FINANCIAL INSTRUMENTS
The recorded amounts of other investments as of September 30, 1994 shown in
the following table include $37 million of equity investments in a number of
entities for which it is not practicable to estimate fair values, since
quoted market prices do not exist for any of these investments.
The fair values of long-term borrowings were estimated based on quoted market
prices or by obtaining quotes from brokers.
The Company is a party to various interest rate option and swap agreements
and foreign currency contracts which are included in other instruments below.
The fair values of other instruments were estimated by obtaining quotes from
brokers, where practicable, or by estimating the amounts the Company would
receive or pay to terminate the instruments at the reporting date.
The recorded amounts of certain financial instruments, such as cash and
marketable securities and short-term borrowings, approximate their fair
values and are excluded from the amounts below. The recorded amounts and
estimated fair values of the Company's long-term borrowings and other
financial instruments as of September 30, 1994 were as follows:
(in millions) Recorded Amount Fair Value
Other investments $ 43 $ 45
Long-term borrowings (4,667) (4,842)
Other instruments (63) (206)
EARNINGS PER COMMON SHARE
Fully diluted earnings per share is computed by dividing net earnings
adjusted for after-tax interest expense associated with convertible
securities by the average number of common shares outstanding, common stock
equivalents related to dilutive stock options, and common shares issuable
upon conversion of such convertible securities. Fully diluted earnings per
share relating to the cumulative effect of changes in accounting principle
were anti-dilutive. The number of common shares used to compute earnings per
share amounts was as follows:
- - --------------------------------------------------------------------------
Third Quarter Three Quarters
(in millions) 1994 1993 1994 1993
- - --------------------------------------------------------------------------
Primary 339.4 328.7 334.3 327.7
Fully Diluted 345.2 359.2 340.2 358.2
- - --------------------------------------------------------------------------
CASH FLOW INFORMATION
Certain debt issues have been converted to equity in non-cash transactions
which are not reflected in the Consolidated Statement of Cash Flows.
8
DISCONTINUED OPERATIONS
On May 3, 1994, the Company announced its intent to divest the following
non-imaging health businesses: the pharmaceutical and consumer health
businesses of Sterling Winthrop Inc., the household products and
do-it-yourself products businesses of L&F Products and the Clinical Diagnostics
Division. These businesses comprise the Health segment, which is reported as
a discontinued operation with results for prior periods restated. On June
23, 1994, the Company announced Sanofi agreed to acquire the pharmaceutical
business of Sterling Winthrop Inc. for $1.675 billion in cash and its
interest in the "Over the Counter" alliance with Sterling Winthrop Inc.
Sanofi's interest in the "Over the Counter" alliance will be transferred to
Sterling Winthrop Inc. On October 1, 1994, the Company completed this sale.
On August 29, 1994, the Company announced SmithKline Beecham plc agreed to
acquire the consumer health business of Sterling Winthrop Inc. for $2.925
billion in cash. On November 2, 1994, the Company completed this sale. On
September 6, 1994, the Company announced Johnson & Johnson agreed to acquire the
Clinical Diagnostics Division for $1.008 billion in cash. On September 26,
1994, the Company announced Reckitt & Coleman plc agreed to acquire the
worldwide household products business of L&F Products for $1.55 billion in
cash. On October 14, 1994, the Company announced Forstmann Little & Co. agreed
to acquire the do-it-yourself products business of L&F Products for
$700 million in cash. In addition, as part of the divestiture, the Company
is actively negotiating with potential buyers for its pharmaceutical research
and development facility and its NanoSystems unit, and anticipates closing
dates for these transactions in 1995.
As of June 30, 1994, the Company concluded that measurement dates had
occurred for the non-imaging health businesses. Accordingly, the financial
statement information related to these businesses has been presented on one
line in the Consolidated Statement of Financial Position, "net assets from
discontinued operations", and in the "discontinued operations" line of the
Consolidated Statement of Earnings. The amounts presented for prior periods
have been restated for comparability. The "net assets from discontinued
operations" represents the assets intended to be sold offset by the
liabilities anticipated to be assumed by the buyers of these businesses. The
amounts presented in the Consolidated Statement of Earnings for prior periods
have been restated to reflect the allocation of interest expense to
discontinued operations. The allocation of interest expense was performed by
reference to the interest expense on indebtedness that is anticipated to be
repaid from the net proceeds received from the sales. The third quarter 1994
loss from the health businesses was deferred and will be recognized as a
reduction of the expected gain on the sale of the health businesses.
The Company currently anticipates an overall gain on the sales of the health
businesses including income from operations during the phase-out period which
is estimated to end on or about December 31, 1994. Consequently, all gains
estimated at this time will be recognized by the Company as such transactions
close.
Summarized results of the Health businesses, including the allocation of
interest expense, are as follows:
Third Quarter Three Quarters
(in millions) 1994 1993 1994 1993
Sales $982 $917 $2,782 $2,703
==== ==== ====== ======
Earnings (loss) before income taxes $(56) $(64) $ (140) $ (203)
Provision (benefit) for income taxes (12) (11) (15) (50)
---- ---- ------ ------
Earnings (loss) before cumulative effect
of changes in accounting principle $(44) $(53) $ (125) $ (153)
==== ==== ====== ======
Interest expense included in earnings (loss) before income taxes was
$115 million for each of the three month periods ended September 30, 1994 and
1993. Interest expense included in earnings (loss) before income taxes was
$344 million and $346 million for the nine month periods ended September 30,
1994 and 1993, respectively.
Net assets of the Health businesses as reported in the Consolidated Statement of Financial
Position are comprised of the following:
Sept. 30, Dec. 31,
(in millions) 1994 1993
Current assets $1,350 $1,165
Land, buildings and equipment, net 1,337 1,339
Other assets 4,214 4,281
------ ------
Total assets 6,901 6,785
------ ------
Current liabilities 926 857
Long-term borrowings 134 126
Other liabilities 480 453
------ ------
Total liabilities 1,540 1,436
------ ------
Net assets of discontinued
operations $5,361 $5,349
====== ======
On June 15, 1993, the Company announced a plan to spin-off its Eastman
Chemical Company operations, which was completed on December 31, 1993.
Summarized results of the Chemicals segment, including the allocation of
interest expense, are as follows:
Third Three
Quarter Quarters
(in millions) 1993 1993
Earnings before cumulative effect of
changes in accounting principle $60 $194
=== ====
10
LONG-TERM BORROWINGS
On October 3, 1994, the Company announced a tender offer for up to $4.8 billion of its
outstanding long-term borrowings. On October 20, 1994, the Company announced that $2.7
billion of the possible $4.8 billion was tendered during the tender offer period which ended
on that date. The table below is provided to disclose the Company's long-term borrowings
following the completion of the tender offer.
Dec. 31 Sept. 30, Oct. 31,
(in millions) 1993 1994 1994
Eastman Kodak Company
10.05% notes due 1994 $ 350 $ - $ -
9.20% notes due 1995 750 750 502
10 3/8% Eurobonds due 1995 111 111 81
7 7/8% notes due 1997 135 135 135
8.55% notes due 1997 200 200 102
9 1/8% notes due 1998 1,100 1,100 528
7 1/4% notes due 1999 275 275 75
9 5/8% notes due 1999 275 275 275
9 1/2% notes due 2000 400 400 244
6 3/8% convertible subordinated
debentures due 2001 278 - -
10% notes due 2001 300 300 122
9 3/8% notes due 2003 400 400 145
9 7/8% notes due 2004 300 300 104
9 3/4% notes due 2004 300 300 97
9 1/2% notes due 2008 300 300 31
Zero coupon convertible subordinated
debentures due 2011 1,127 - -
9.95% debentures due 2018 125 125 3
9.20% debentures due 2021 200 200 9
Sterling Winthrop Inc.
8 7/8% notes due 1996 100 100 100
Industria Fotografica
Interamericana S.A. de C.V.
7.36% notes due 2003 110 110 110
Qualex Inc. - 215 68
Other 67 66 75
------ ------ ------
7,203 5,662 2,806
Less: Current maturities 350 861 583
------ ------ ------
6,853 4,801 2,223
Less: Amounts expected to be assumed
by discontinued operations 126 134 134
------ ------ ------
Total $6,727 $4,667 $2,089
====== ====== ======
SUBSEQUENT EVENTS
In connection with the debt paydown program, the Company incurred pre-tax
losses related to the tender offer of approximately $160 million which will
result in an extraordinary charge in the fourth quarter of 1994. The Company
has also unwound substantially all of the interest rate derivatives
associated with its debt issues. The Company incurred pre-tax losses related
to the unwind of the derivatives of approximately $160 million in September,
which has been deferred, and approximately $60 million in October. These
losses will be charged to extraordinary and other charges in the fourth
quarter of 1994 along with the losses on the debt.
Harry L. Kavetas, Executive Vice President
and Chief Financial Officer
November 14, 1994
11
Management's Discussion and Analysis of Financial Condition and Results of
Operations
SUMMARY
(in millions, except Third Quarter Three Quarters
earnings per share) 1994 1993 Change 1994 1993 Change
Sales from continuing operations $3,529 $3,160 +12% $9,709 $ 9,181 +6%
Earnings (loss) from operations
before extraordinary item and
cumulative effect of changes
in accounting principle:
Continuing 193 (74) 633 424
Discontinued-Health - (53) (81) (153)
Discontinued-Chemicals - 60 - 194
Net earnings (loss) 193 (68) 539 (1,716)
Primary earnings (loss)
per share .57 (.21) 1.61 (5.24)
Fully diluted earnings (loss)
per share .56 (.15) 1.58 (5.24)
Sales from continuing operations of $3,529 million for the third quarter of
1994 were up significantly when compared with the third quarter of 1993.
Excluding the sales of Qualex, which was acquired on August 12, 1994, the
Company recorded good sales increases for the quarter. Year-to-date sales
from continuing operations of $9,709 million were moderately higher than sales
for the comparable period of last year. Earnings from continuing operations
were adversely affected by restructuring costs in 1993 of $495 million
($353 million or $1.08 per share after-tax). Third quarter earnings from
continuing operations decreased substantially from the third quarter of 1993,
before deducting the effects of restructuring costs, as the benefits of
increased unit volumes and manufacturing productivity were more than offset by
cost escalation, higher marketing and administrative expenses, lower effective
selling prices and incremental charges associated with our continuing review
of the carrying value of all assets. Year-to-date earnings from continuing
operations decreased significantly from the comparable period a year ago,
before deducting the effects of restructuring costs, as the benefits of
increased unit volumes and manufacturing productivity were more than offset by
cost escalation, lower effective selling prices, and incremental charges
associated with our continuing review of the carrying value of all assets. In
addition, the 1993 third quarter and year-to-date net earnings benefited from
net gains on strategic currency hedges of approximately $17 million and $38
million, respectively, and from the sales of assets. The 1994 third quarter
and year-to-date net earnings were adversely impacted by premium costs for
strategic currency hedges of approximately $15 million and $38 million,
respectively, and by the initial consolidation of Qualex. Net earnings for
the year-to-date periods of both years included an extraordinary charge of
$.04 per share related to the early extinguishment of debt.
The 1993 year-to-date net loss was due to an after-tax charge of $2.17 billion
($6.62 per share) associated with the adoption of Statement of Financial
Accounting Standards (SFAS) No. 106, Employers' Accounting for Postretirement
Benefits Other Than Pensions, and SFAS No. 112, Employers' Accounting for
Postemployment Benefits effective as of January 1, 1993.
On May 3, 1994, the Company announced its intent to divest the following
non-imaging health businesses: the pharmaceutical and consumer health
businesses of Sterling Winthrop Inc., the household products and
do-it-yourself products businesses of L&F Products and the Clinical Diagnostics
Division. These businesses are reported as discontinued operations with
results for prior periods restated. On June 23, 1994, the Company announced
Sanofi agreed to acquire the pharmaceutical business of Sterling Winthrop Inc.
for $1.675 billion in cash and its interest in the "Over the Counter" alliance
with Sterling Winthrop Inc. On October 1, 1994, the Company completed this
sale. On August 29, 1994, the Company announced SmithKline Beecham plc agreed
to acquire the consumer health business of Sterling Winthrop Inc. for $2.925
billion in cash. On November 2, 1994, the Company completed this sale. On
September 6, 1994, the Company announced Johnson & Johnson agreed to acquire the
Clinical Diagnostics Division for $1.008 billion in cash. On September 26,
1994, the Company announced Reckitt & Colman plc agreed to acquire the worldwide
household products business of L&F Products for $1.55 billion in cash. On
October 14, 1994, the Company announced Forstmann Little & Co. agreed to acquire
the do-it-yourself products business of L&F Products for $700 million in
cash. In addition, as part of the divestiture, the Company is actively
negotiating with potential buyers for its pharmaceutical research and
development facility and its NanoSystems unit, and anticipates closing dates
for these transactions in 1995. The third quarter 1994 loss from the
discontinued health operations of $44 million or $.13 per share, was deferred
and will be recognized as a reduction of the expected gain on the sale of
the health business, which is anticipated to be recorded in the fourth quarter.
12
On August 12, 1994, the company purchased from the Actava Group Inc. its 50%
interest in Qualex for $150 million, $50 million to Actava at the closing and
the remaining $100 million without interest in two installments over the next
twelve months. As a result of this transaction, Qualex is now a wholly owned
subsidiary of the Company and its financial statements are consolidated with
those of the Company beginning in the third quarter.
On October 7, 1994, the Company announced settlement of a civil complaint by
the Environmental Protection Agency (EPA) alleging noncompliance with federal
environmental regulations at the Company's Kodak Park manufacturing site.
The Company has been assessed a $5 million penalty, previously accrued, and
has also agreed to conduct a number of special environmental projects over an
eight-year period. The costs of these improvement projects will be expensed
or capitalized as incurred in accordance with the Company's accounting policy
for environmental costs.
On October 25, 1994, the Company announced in its third quarter earnings
release that its focus on cost management would continue and could possibly
include a restructuring program in the fourth quarter of 1994, which could
have a material impact on the results of operations.
On June 15, 1993, the Company announced a plan to spin-off its Eastman
Chemical Company operations, which was completed on December 31, 1993.
SEGMENT SALES
In the Consumer Imaging segment, sales to customers inside the U.S. showed an
excellent increase for the quarter and were up significantly year to date,
when compared with sales for the same periods of 1993, due primarily to the
initial consolidation of Qualex. Excluding the sales of Qualex, sales for
the quarter and year to date increased moderately over the comparable periods
of 1993 as higher volumes were partially offset by lower effective selling
prices. Outside the U.S., sales recorded a strong increase in the quarter as
solid volume increases and the favorable effects of foreign currency rate
changes were only partially offset by the unfavorable effects of lower
effective selling prices. Year to date, sales to customers outside the U.S.
showed a good increase, as solid increases in unit volumes were only
partially offset by the unfavorable effects of lower effective selling
prices. Worldwide volume gains in the 1994 third quarter and year to date
were led by single-use cameras, Ektacolor papers and Kodacolor 35mm films.
In the Commercial Imaging segment, the slight increases in sales to customers
inside the U.S. for the quarter and year to date were due to volume
increases. Good increases in sales to customers outside the U.S. in the
third quarter of 1994 were due to good volume gains and the favorable effects
of foreign currency rate changes, partially offset by lower effective selling
prices. For the first three quarters of 1994, sales to customers outside the
U.S. increased slightly as higher volumes were partially offset by lower
effective selling prices. Worldwide sales increases in the quarter and year
to date were led by health sciences, printing and publishing imaging, and
motion picture and television products.
Sales by Segment
Third Quarter Three Quarters
(in millions) 1994 1993 Change 1994 1993 Change
Sales from Continuing Operations
Consumer Imaging
Inside the U.S. $ 645 $ 516 25% $1,646 $1,475 12%
Outside the U.S. 968 836 16 2,532 2,346 8
------ ------ -- ------ ------ --
Total Consumer Imaging 1,613 1,352 19 4,178 3,821 9
------ ------ -- ------ ------ --
Commercial Imaging
Inside the U.S. 996 964 3 2,861 2,803 2
Outside the U.S. 920 844 9 2,670 2,559 4
------ ------ -- ------ ------ --
Total Commercial Imaging 1,916 1,808 6 5,531 5,362 3
------ ------ -- ------ ------ --
Deduct Intersegment Sales - - - (2)
------ ------ -- ------ ------ --
Total Sales from
Continuing Operations $3,529 $3,160 12% $9,709 $9,181 6%
====== ====== == ====== ====== ==
- - --------------------------------------------------------------------------
13
COSTS AND EXPENSES
Third Quarter Three Quarters
(in millions) 1994 1993 Change 1994 1993 Change
Cost of goods sold $1,967 $1,625 21% $5,219 $4,688 11%
Percent of Sales 55.7% 51.4% 53.8% 51.1%
Marketing and administrative
expenses $ 972 $ 829 17% $2,644 $2,499 6%
Percent of Sales 27.5% 26.2% 27.2% 27.2%
Research and development costs $ 221 $ 231 -4% $ 655 $ 648 1%
Percent of Sales 6.3% 7.3% 6.7% 7.1%
Cost of goods sold for the third quarter of 1994 included goodwill
amortization of $14 million compared with $10 million in the third quarter of
1993. For the 1994 year to date, goodwill amortization was $31 million
compared with $23 million for the 1993 year to date. The increases in the
cost of goods sold percentages for the quarter and year to date were
primarily due to the adverse impacts of cost escalation, lower effective
selling prices, the initial consolidation of Qualex and incremental charges
associated with our continuing review of the carrying value of all assets.
The increases in marketing and administrative expenses in the quarter and
year to date when compared with 1993 were primarily due to the initial
consolidation of Qualex, cost escalation and incremental charges associated
with our continuing review of the carrying value of all assets. Research and
development costs recorded a decrease in the quarter and were essentially
level year to date compared with last year as lower activity levels offset
cost escalation.
SEGMENT EARNINGS
Consumer Imaging operating earnings were adversely affected by restructuring
costs in 1993 of $141 million. Consumer Imaging operating earnings for the
1994 third quarter decreased substantially when compared with the 1993 third
quarter, before deducting restructuring costs, as the benefits of increased
unit volumes and manufacturing productivity were more than offset by lower
effective selling prices, cost escalation, incremental charges associated
with our continuing review of the carrying value of all assets, and higher
research and development activity. Year-to-date Consumer Imaging operating
earnings, before deducting restructuring costs in 1993, decreased as the
benefits of increased unit volumes and manufacturing productivity were more
than offset by lower effective selling prices, cost escalation and
incremental charges associated with our continuing review of the carrying
value of all assets. In addition, the 1993 third quarter and year to date
benefited from the positive effect of strategic currency hedges, while the
1994 third quarter and year to date were adversely impacted by the premium
costs for strategic currency hedges.
Commercial Imaging operating earnings were adversely affected by
restructuring costs in 1993 of $354 million. Commercial Imaging segment
operating earnings for the 1994 third quarter and year to date were
substantially lower than earnings for the comparable periods a year ago,
before deducting restructuring costs. In the quarter, the benefits of
increased unit volumes and lower research and development activity were more
than offset by cost escalation, lower effective selling prices and
incremental charges associated with our continuing review of the carrying
value of all assets. For the year to date, the benefits of increased unit
volumes, lower marketing and administrative activity and lower research and
development activity were more than offset by cost escalation, lower
effective selling prices and incremental charges associated with our
continuing review of the carrying value of all assets. In addition, the 1993
third quarter and year to date benefited from the positive effect of
strategic currency hedges, while the 1994 third quarter and year to date were
adversely impacted by the premium costs for strategic currency hedges.
- - -------------------------------------------------------------------------
14
Earnings (loss) from
Operations by Segment
Third Quarter Three Quarters
Excluding Restructuring Costs Excluding Restructuring Costs
(in millions) 1994 1993 Change 1994 1993 Change
Earnings from Operations
from Continuing Operations
Consumer Imaging $ 269 $ 333 -19% $ 756 $ 799 -5%
Percent of Sales 16.7% 24.6% 18.1% 20.9%
Commercial Imaging $ 94 $ 153 -39% $ 423 $ 554 -24%
Percent of Sales 4.9% 8.5% 7.6% 10.3%
------ ------ ---- ------ ------ ----
Total Earnings from Operations
from Continuing Operations $ 363 $ 486 -25% $1,179 $1,353 -13%
====== ====== ==== ====== ====== ====
Earnings (loss) from
Operations by Segment
Third Quarter Three Quarters
Including Restructuring Costs Including Restructuring Costs
1994 1993 Change 1994 1993 Change
Earnings (loss) from Operations
from Continuing Operations
Consumer Imaging $ 269 $ 192 40% $ 756 $ 658 15%
Percent of Sales 16.7% 14.2% 18.1% 17.2%
Commercial Imaging $ 94 $ (201) $ 423 $ 200 112%
Percent of Sales 4.9% (11.1%) 7.6% 3.7%
------ ------ ---- ------ ------ ----
Total Earnings (loss) from
Operations from Continuing
Operations $ 363 $ (9) $1,179 $ 858 37%
====== ====== ==== ====== ====== ====
- - --------------------------------------------------------------------------------------------
15
OTHER REVENUES AND COSTS
Earnings from equity interests and other revenues were lower in the quarter
and year to date when compared with the comparable periods of 1993. The
decreases were due to lower earnings from equity interests, lower investment
income and the inclusion of gains from the sale of assets and other items in
1993. The net effect from foreign exchange transactions was a loss of
$6 million in the quarter and a loss of $50 million for the year to date
compared with a loss of $1 million in the 1993 third quarter and a loss of
$23 million in the 1993 year to date, respectively. For continuing
operations, the year-to-date effective tax rate was 37.6%, compared with
42.7% for the 1993 year to date. The higher rate in 1993 was primarily due
to the effects of certain non-deductible restructuring charges.
- - ---------------------------------------------------------------------------
Third Quarter Three Quarters
Net Earnings (Loss) 1994 1993 1994 1993
(in millions)
Amount $193 $(68) $539 $(1,716)
Percent of Sales 5.5%
- - ----------------------------------------------------------------------------
CASH DIVIDENDS
During the third quarter of 1994, a cash dividend of $136 million ($.40 per
share) was declared on the Company's common stock. Total dividends declared
for the year to date amounted to $401 million ($1.20 per share). Total
dividends declared during the 1993 year to date were $492 million ($1.50 per
share).
FINANCIAL POSITION
Cash and marketable securities were $727 million at the end of the third
quarter, compared with $1,966 million at year-end 1993. In connection with
the spin-off of the worldwide chemical business at the end of 1993, the
Company borrowed $1.8 billion in December, 1993. The borrowings were
subsequently assumed by the worldwide chemical business on December 31, 1993.
The proceeds from the borrowings, which were retained by Kodak, were used
during the first nine months of 1994 to redeem debt and interest rate
derivatives, and terminate a Master Lease agreement and a Sale of Receivables
program. Short-term borrowings increased $1,849 million, while long-term
borrowings decreased $2,060 million from year-end 1993. The Company has been
increasing short-term borrowings to redeem long-term borrowings until
proceeds are received from the divestitures of the non-imaging health
businesses. Working capital at the end of the quarter decreased to
$407 million compared with $2,804 million at year-end 1993.
The increase in Capital Stock and Additional Paid-In-Capital since year-end
1993 is primarily attributable to the partial conversion of the 6 3/8%
convertible subordinated debentures and zero coupon convertible subordinated
debentures into Company stock.
The Company expects to have positive operating cash flow for the year and
plans to use the proceeds from the divestitures of the non-imaging health
businesses to further reduce debt and interest rate derivatives, which will
result in material extraordinary and other charges from the early
extinguishment of debt and related interest rate derivatives. On October 3,
1994, the Company announced a tender offer for up to $4.8 billion of its
long-term borrowings. On October 20, 1994, the Company announced that $2.7
billion of the possible $4.8 billion had been tendered during the tender
offer period, which ended on that date. The Company incurred pre-tax losses
related to the tender offer of approximately $160 million which will result
in an extraordinary charge in the fourth quarter of 1994. The Company has
also unwound substantially all of the interest rate derivatives associated
with its debt issues. The Company incurred pre-tax losses related to the
unwind of the derivatives of approximately $160 million in September, which
has been deferred, and approximately $60 million in October. These losses
will be charged to extraordinary and other charges in the fourth quarter of
1994 along with the losses on the debt.
CAPITAL ADDITIONS
Capital additions for the third quarter of 1994 were $187 million compared
with $174 million for the third quarter of 1993. For the 1994 year to date,
capital additions were $814 million versus $612 million a year ago. The
Company was a party to a Master Lease agreement whereby the Company could
lease equipment with the right to buy the equipment anytime at fair market
value. The Company terminated this agreement during the second quarter of
1994 by purchasing approximately $300 million of equipment it has been
leasing. The provision for depreciation for the first three quarters of 1994
was $582 million, compared with $616 million for the comparable period of 1993.
- - ----------------------------------------------------------------------------
16
Part II. OTHER INFORMATION
Item 1. Legal Proceedings
On October 7, the Company and the US Environmental Protection Agency (EPA)
and Department of Justice (DOJ) announced settlement of a civil complaint
alleging noncompliance by the Company with federal environmental regulations
at the Company's Kodak Park manufacturing site in Rochester, N.Y. The
Company was assessed a penalty of $5 million, and also agreed to conduct a
number of special environmental projects over an eight-year period as an
offset to $3 million in additional penalties. A consent decree was signed
under which the Company is subject to a 12-year compliance schedule
requiring, among other things, that the Company improve the characterization
of its waste, evaluate and upgrade its industrial sewer system, and upgrade
one of its incinerators.
The Company is participating in the EPA's Toxic Substances Control Act (TSCA)
Section 8 (e) Compliance Audit Program. As a participant, the Company has
agreed to audit its files for materials which under current EPA guidelines
would be subject to notification under Section 8 (e) of TSCA and to pay
stipulated penalties for each report submitted under this program. The
Company anticipates that its liability under the Program will be $1,000,000.
In addition to the foregoing environmental actions, the Company has been
designated as a potentially responsible party (PRP) under the Comprehensive
Environmental Response Compensation and Liability Act of 1980, as amended
(the "Superfund" law), or under similar state laws, for environmental
assessment and cleanup costs as the result of the Company's alleged
arrangements for disposal of hazardous substances at fewer than twenty
Superfund sites. With respect to each of these sites, the Company's actual
or potential allocated share of responsibility is small. Furthermore,
numerous other PRPs have similarly been designated at these sites and,
although the law imposes joint and several liability on PRPs, as a practical
matter costs are shared with other PRPs. Settlements and costs paid by the
Company in Superfund matters to date have not been material. Future costs
are also not expected to be material to the Company's financial condition or
results of operations.
The Company and its subsidiary companies are involved in lawsuits, claims,
investigations, and proceedings, including product liability, commercial,
environmental, and health and safety matters, which are being handled and
defended in the ordinary course of business. There are no such matters
pending that the Company and its General Counsel expect to be material in
relation to the Company's business, financial condition, or results of
operations.
Item 5. Other Information
Effective October 31, 1994, the Company completed the divestiture of its
Sterling Winthrop Inc. subsidiary to SmithKline Beecham for $2.925 billion in
cash. Details of the divestiture are contained in a press release issued by
the Company on November 2, 1994, and set forth herein as Exhibit 99. Pro
forma consolidated financial statements of the Company for the year ended
December 31, 1993, excluding the results of the non-imaging health businesses
(including Sterling Winthrop Inc.) that the Company is divesting, are set
forth at Item 7 of Current Report on Form 8-K dated June 30, 1994 and filed
October 17, 1994, as amended by Amendment No. 1 to Current Report on Form 8-K
dated June 30, 1994 and filed October 21, 1994.
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits and financial statement schedules required as part of
this report are listed in the index appearing on page 18.
(b) Reports on Form 8-K
No reports on Form 8-K were filed or required to be filed for
the quarter ended September 30, 1994.
17
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
EASTMAN KODAK COMPANY
(Registrant)
Date November 14, 1994
Harry L. Kavetas, Executive Vice President
and Chief Financial Officer
18
Eastman Kodak Company and Subsidiary Companies
Index to Exhibits and Financial Statement Schedules
Page No.
11. Three Quarters 1994 Computation of Earnings
Per Common Share, Exhibit (11) 19-21
99. November 2, 1994 Press Release 22
10(A). Stock Purchase Agreement among Eastman Kodak Company,
343 Holding Corporation and SmithKline Beecham plc -
Dated as of August 28, 1994. 23-158
10(B). Amendment to the Stock Purchase Agreement among Eastman
Kodak Company, L&F Products Inc. and SmithKline Beecham
plc - Dated as of October 30, 1994. 159-177
10(C). Asset Purchase Agreement by and between Eastman Kodak
Company and Johnson & Johnson - Dated as of
September 2, 1994. 178-272
10(D). Asset Purchase Agreement among Eastman Kodak Company
and L&F Products Inc. and Sterling Winthrop Inc. and
Reckitt & Colman plc - Dated as of September 26, 1994. 273-410
10(E). Amendment to the Asset Purchase Agreement among Eastman
Kodak Company and L&F Products Inc. and Sterling Winthrop
Inc. and Reckitt & Colman plc - Dated as of
October 28, 1994. 411-412
10(F). Asset Purchase Agreement among Eastman Kodak and L&F
Products Inc. and Sterling Winthrop Inc. and MTF
Acquisition Corp. - Dated as of October 13, 1994. 413-533
27. Financial Data Schedule, Exhibit (27) - Submitted
with the EDGAR filing as a second document to this
Form 10-Q.
19
Eastman Kodak Company and Subsidiary Companies
Exhibit (11)
Computation of Earnings Per Common Share
Third Quarter Three Quarters
1994 1993 1994 1993
(in millions, except per share amounts)
PRIMARY:
Earnings (loss) from continuing operations
before extraordinary item and cumulative
effect of changes in accounting principle $ 193 $ (74) $ 633 $ 424
Earnings (loss) from discontinued operations
before cumulative effect of changes in
accounting principle - 7 (81) 41
------ ------ ------- -------
Earnings (loss) before extraordinary item and
cumulative effect of changes
in accounting principle 193 (67) 552 465
Extraordinary item - (1) (13) (13)
------ ------ ------- -------
Earnings (loss) before cumulative effect of
changes in accounting principle 193 (68) 539 452
------ ------ ------- -------
Cumulative effect of changes in accounting
principle from continuing operations - - - (1,649)
Cumulative effect of changes in accounting
principle from discontinued operations - - - (519)
------ ------ ------- -------
Total cumulative effect of changes in
accounting principle - - - (2,168)
------ ------ ------- -------
Net Earnings (Loss) $ 193 $ (68) $ 539 $(1,716)
====== ====== ======= =======
Average number of common shares outstanding 339.4 328.7 334.3 327.7
Primary earnings (loss) per share from
continuing operations before extraordinary
item and cumulative effect of changes in
accounting principle $ .57 $ (.23) $ 1.89 $ 1.29
Primary earnings (loss) per share from
discontinued operations before cumulative
effect of changes in accounting principle - .02 (.24) .13
------ ------ ------- -------
Primary earnings (loss) per share before
extraordinary item and cumulative effect of
changes in accounting principle .57 (.21) 1.65 1.42
Extraordinary item - - (.04) (.04)
------ ------ ------- -------
Primary earnings (loss) per share before
cumulative effect of changes in accounting
principle .57 (.21) 1.61 1.38
------ ------ ------- -------
Cumulative effect of changes in accounting
principle from continuing operations - - - (5.04)
Cumulative effect of changes in accounting
principle from discontinued operations - - - (1.58)
------ ------ ------- -------
Total cumulative effect of changes in
accounting principle - - - (6.62)
------ ------ ------- -------
Primary earnings (loss) per share $ .57 $ (.21) $ 1.61 $ (5.24)
====== ====== ======= =======
20
Eastman Kodak Company and Subsidiary Companies
Exhibit (11)
(Continued)
Computation of Earnings Per Common Share
Third Quarter Three Quarters
(in millions) 1994 1993 1994 1993
FULLY DILUTED:
Earnings (loss) from continuing operations
before extraordinary item and cumulative
effect of changes in accounting principle $ 193 $ (74) $ 633 $ 424
Add after-tax interest expense applicable to:
6 3/8% convertible debentures - 3 - 9
Zero coupon convertible debentures - 11 - 33
------ ------ ------ -------
Adjusted earnings (loss) from continuing
operations before extraordinary item and
cumulative effect of changes in
accounting principle 193 (60) 633 466
Earnings (loss) from discontinued operations
before cumulative effect of changes in
accounting principle - 7 (81) 41
------ ------ ------ -------
Adjusted earnings (loss) before extraordinary
item and cumulative effect of changes in
accounting principle 193 (53) 552 507
Extraordinary item - (1) (13) (13)
------ ------ ------ -------
Adjusted earnings (loss) before cumulative
effect of changes in accounting principle 193 (54) 539 494
------ ------ ------ -------
Cumulative effect of changes in accounting
principle from continuing operations - - - (1,649)
Cumulative effect of changes in accounting
principle from discontinued operations - - - (519)
------ ------ ------ -------
Total cumulative effect of changes in
accounting principle - - - (2,168)
------ ------ ------ -------
Adjusted net earnings (loss) $ 193 $ (54) $ 539 $(1,674)
====== ====== ====== =======
21
Eastman Kodak Company and Subsidiary Companies
Exhibit (11)
(Continued)
Computation of Earnings Per Common Share
Third Quarter Three Quarters
1994 1993 1994 1993
(in millions, except per share amounts)
Average number of common shares outstanding 339.4 328.7 334.3 327.7
Add-incremental shares under option 5.8 3.9 5.9 3.9
Add-incremental shares applicable to:
6 3/8% convertible debentures - 5.9 - 5.9
Zero coupon convertible debentures - 20.7 - 20.7
------ ------ ------ ------
Adj'd avg. number of shares outstanding 345.2 359.2 340.2 358.2
------ ------ ------ ------
Fully diluted earnings (loss) per share from
continuing operations before extraordinary
item and cumulative effect of changes in
accounting principle $ .56 $ (.17) $ 1.86 $ 1.29
Fully diluted earnings (loss) per share from
discontinued operations before cumulative
effect of changes in accounting principle - .02 (.24) .12
------ ------ ------ ------
Fully diluted earnings (loss) per share before
extraordinary item and cumulative effect of
changes in accounting principle .56 (.15) 1.62 1.41
Extraordinary item - - (.04) (.03)
------ ------ ------ ------
Fully diluted earnings (loss) per share before
cumulative effect of changes in
accounting principle .56 (.15) 1.58 1.38
------ ------ ------ ------
Cumulative effect of changes in accounting
principle from continuing operations - - - (5.04)
Cumulative effect of changes in accounting
principle from discontinued operations - - - (1.58)
------ ------ ------ ------
Total cumulative effect of changes in
accounting principle - - - (6.62)
------ ------ ------ ------
Fully diluted earnings (loss) per share $ .56 $ (.15) $ 1.58 $(5.24)
====== ====== ====== ======
22
Exhibit (99)
KODAK COMPLETES STERLING WINTHROP SALE
TO SMITHKLINE BEECHAM
Rochester, N.Y., November 2 -- Eastman Kodak Company announced the completion
of the sale of its Sterling Winthrop Inc. subsidiary to SmithKline Beecham for
$2.925 billion in cash.
SmithKline Beecham purchased 100 percent of the stock of Sterling Winthrop and
thereby acquired the company's worldwide consumer health products business.
SmithKline Beecham has previously announced an agreement to sell the North
American segment of Sterling Winthrop's consumer health products business to
Miles, Inc. a wholly-owned subsidiary of Bayer, AG, of Germany.
The sale marks the second completed transaction in Kodak's divestiture program.
On October 1, Kodak completed the sale of Sterling Winthrop's pharmaceuticals
business to Sanofi, SA, of France for $1.675 billion in cash. Previously
announced agreements for the sale of the Household Products, the DIY Products
business of Kodak's L&F Products unit, and of Kodak's Clinical Diagnostics
business should be completed before year end.
Kodak also will sell Sterling Winthrop's research and development center,
located near Philadelphia, Pa., and its NanoSystems unit in separate
transactions.
NanoSystems is a technology development unit organized to commercialize Kodak's
proprietary small particle development (at the sub-micron level) technology for
pharmaceutical applications. A number of potentially promising drug
applications are in development.
23
Exhibit 10(A)
STOCK PURCHASE AGREEMENT
among
EASTMAN KODAK COMPANY
343 HOLDING CORPORATION
and
SMITHKLINE BEECHAM plc
Dated as of August 28, 1994
Circulated September 2, 1994
24
TABLE OF CONTENTS
Page
ARTICLE I
DEFINITIONS AND TERMS
Section 1.1 Specific Definitions . . . . . . . . . . . 33
Section 1.2 Other Terms. . . . . . . . . . . . . . . . 45
Section 1.3 Other Definitional Provisions. . . . . . . 45
ARTICLE II
PURCHASE OF COMMON STOCK
Section 2.1 Purchase and Sale of Common Stock. . . . . 45
Section 2.2 Post-Closing Adjustments . . . . . . . . . 46
Section 2.3 Closing; Delivery and Payment. . . . . . . 50
Section 2.4 Puerto Rican Cash. . . . . . . . . . . . . 51
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF SELLER
Section 3.1 Organization, Qualification and
Authority of Seller. . . . . . . . . . . 55
Section 3.2 Binding Effect . . . . . . . . . . . . . . 56
Section 3.3 Organization, Qualification and
Authority of Sterling. . . . . . . . . . 56
Section 3.4 Ownership of Shares. . . . . . . . . . . . 57
Section 3.5 Investments; Joint Ventures, etc. . . . . 57
Section 3.6 Consents and Approvals . . . . . . . . . . 59
Section 3.7 Non-Contravention. . . . . . . . . . . . . 60
Section 3.8 Financial Statements . . . . . . . . . . . 61
Section 3.9 Litigation and Claims. . . . . . . . . . .
62
25
Section 3.10 Taxes. . . . . . . . . . . . . . . . . . . 63
Section 3.11 Employee Benefits. . . . . . . . . . . . . 65
Section 3.12 Compliance with Laws . . . . . . . . . . . 68
Section 3.13 Intellectual Property. . . . . . . . . . . 68
Section 3.14 Labor Matters; Collective
Bargaining Agreements. . . . . . . . . . 70
Section 3.15 Contracts. . . . . . . . . . . . . . . . . 70
Section 3.16 Title to Property. . . . . . . . . . . . . 71
Section 3.17 Absence of Change. . . . . . . . . . . . . 72
Section 3.18 Finders' Fees. . . . . . . . . . . . . . . 73
Section 3.19 Continuing Service and Supply
Arrangements . . . . . . . . . . . . . . 74
Section 3.20 Insurance. . . . . . . . . . . . . . . . . 74
Section 3.21 No Undisclosed Liability . . . . . . . . . 75
Section 3.22 Environmental Matters. . . . . . . . . . . 75
Section 3.23 Other Information. . . . . . . . . . . . . 76
Section 3.24 No Other Representations or Warranties . . 77
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF PURCHASER
Section 4.1 Organization and Qualification . . . . . . 77
Section 4.2 Binding Effect . . . . . . . . . . . . . . 77
Section 4.3 Corporate Authorization. . . . . . . . . . 78
Section 4.4 Consents and Approvals . . . . . . . . . . 78
Section 4.5 Non-Contravention. . . . . . . . . . . . . 79
Section 4.6 Finders' Fees. . . . . . . . . . . . . . .
80
26
Section 4.7 Financial Capability . . . . . . . . . . . 80
Section 4.8 Securities Act . . . . . . . . . . . . . . 80
Section 4.9 No Other Representations or Warranties . . 80
ARTICLE V
COVENANTS
Section 5.1 Access . . . . . . . . . . . . . . . . . . 81
Section 5.2 Conduct of Business. . . . . . . . . . . . 84
Section 5.3 Best Efforts; Good Faith;
Cooperation in Restructuring . . . . . . 88
Section 5.4 Tax Matters. . . . . . . . . . . . . . . . 91
Section 5.5 Post-Closing Obligations to
Certain Employees . . . . . . . . . . . 110
Section 5.6 Compliance with WARN, etc . . . . . . . . 119
Section 5.7 Notification of Certain Matters. . . . . 119
Section 5.8 License Agreements . . . . . . . . . . . .120
Section 5.9 Certain Provisions Relating to
the Restructuring. . . . . . . . . . . .121
Section 5.10 Transfer of Certain Assets and
Liabilities. . . . . . . . . . . . . . .131
Section 5.11 Financial Information. . . . . . . . . . .132
Section 5.12 Retained Employees . . . . . . . . . . . .132
Section 5.13 Management of Certain Liabilities. . . . .132
Section 5.14 Further Assurances . . . . . . . . . . . .134
Section 5.15 Resignations . . . . . . . . . . . . . .
.134
27
ARTICLE VI
CONDITIONS TO CLOSING
Section 6.1 Conditions to the Obligations of
Purchaser and Seller . . . . . . . . . .135
Section 6.2 Conditions to the Obligations of
Purchaser. . . . . . . . . . . . . . . .136
Section 6.3 Conditions to the Obligations of
Seller . . . . . . . . . . . . . . . . .137
ARTICLE VII
SURVIVAL; INDEMNIFICATION
Section 7.1 Survival . . . . . . . . . . . . . . . . .138
Section 7.2 Indemnification by Purchaser . . . . . . .139
Section 7.3 Indemnification by Seller. . . . . . . . .140
Section 7.4 Indemnification Procedures . . . . . . . .144
Section 7.5 Characterization of Indemnification
Payments . . . . . . . . . . . . . . . .147
Section 7.6 Computation of Losses Subject to
Indemnification. . . . . . . . . . . . .147
ARTICLE VIII
TERMINATION
Section 8.1 Termination. . . . . . . . . . . . . . . .148
Section 8.2 Effect of Termination. . . . . . . . . . .149
28
ARTICLE IX
MISCELLANEOUS
Section 9.1 Notices. . . . . . . . . . . . . . . . . .150
Section 9.2 Amendment; Waiver. . . . . . . . . . . . .151
Section 9.3 Assignment . . . . . . . . . . . . . . . .152
Section 9.4 Entire Agreement . . . . . . . . . . . . .153
Section 9.5 Fulfillment of Obligations . . . . . . . .153
Section 9.6 Parties in Interest. . . . . . . . . . . .154
Section 9.7 Public Disclosure. . . . . . . . . . . . .154
Section 9.8 Return of Information. . . . . . . . . . .154
Section 9.9 Expenses . . . . . . . . . . . . . . . . .155
Section 9.10 Schedules. . . . . . . . . . . . . . . . .155
Section 9.11 GOVERNING LAW; SUBMISSION TO
JURISDICTION; SELECTION OF FORUM . . . .155
Section 9.12 Counterparts . . . . . . . . . . . . . . .156
Section 9.13 Headings . . . . . . . . . . . . . . . . .156
Section 9.14 Severability . . . . . . . . . . . . . . .157
Section 9.15 Structure. . . . . . . . . . . . . . . . .157
29
SCHEDULES AND EXHIBITS
ANNEXES
Annex 6.2(c) - Opinion of Seller's Counsel
Annex 6.3(c) - Opinion of Purchaser's Counsel
30
SCHEDULES
Schedule 1.1 - Certain Changes
Schedule 2.4(a) - Puerto Rican Cash Schedule
2.4(d) - Puerto Rican Repatriation Schedule 3.3
- - - Organization, Qualification and
Authority of Sterling
Schedule 3.4 - Ownership of Shares Schedule
3.5(a)(i) - Investments; Joint Ventures, etc. Schedule
3.5(a)(ii) - Subsidiaries
Schedule 3.5(b) - Capital Stock of Subsidiaries
Schedule 3.6 - Consents and
Approvals Schedule 3.7 -
Non-Contravention Schedule 3.8(a)(i) -
Financial Statements Schedule 3.8(a)(ii) -
Basis of Presentation and
Exceptions to GAAP Schedule
3.8(c)(i) - Consumer Health Business Net
Sales and Earnings
Schedule 3.8(c)(ii) - Consumer Health Business
Worldwide Net Sales
Schedule 3.9(a) - Litigation and Claims
Schedule 3.9(b) - Orders and Judgments
Schedule 3.10 - Taxes
Schedule 3.11(a) - Benefit Plans
Schedule 3.11(b) - Benefit Plan Litigation
Schedule 3.11(f) - Retiree Benefits
Schedule 3.11(g) - Unfunded Liabilities
Schedule 3.12 - Compliance with Laws
Schedule 3.13(a) - Intellectual Property
Schedule 3.13(b)(i) - Intellectual Property
Infringement - Non-Trademark
Schedule 3.13(b)(ii) - Selected Marks
Schedule 3.13(b)(iii) - Intellectual Property
Infringement - Trademark
Schedule 3.14 - Collective Bargaining Agreements
Schedule 3.15(i) - Contracts
Schedule 3.15(ii) - Validity of Contracts
Schedule 3.15(iii) - Contracts in Default
Schedule 3.16(a) -
Encumbrances Schedule 3.20 -
Insurance Schedule 3.22(b) - Certain Environmental
Matters Schedule 4.1 - Organization and
Qualification Schedule 4.4 - Purchaser Consents
and Approvals Schedule 4.5 - Non-Contravention
Schedule 5.9(j) - Transitional Services Employees
Schedule 5.10(i) - Transferred Real Property
Schedule 5.10(ii) - Transferred Fixtures and
Equipment
Schedule 5.10(iv) - Other Transferred Items
Schedule 5.12 - Retained Employees
Schedule 5.13(a) - Management of Certain
Liabilities
31
Schedule 7.3(a)(i) - Disclosed OTC Environmental
Liabilities
Schedule 7.3(a)(ii) - Certain Retained Liabilities
32
STOCK PURCHASE AGREEMENT, dated as of August 28,
1994, among EASTMAN KODAK COMPANY, a New Jersey corporation
("Seller") and 343 HOLDING CORPORATION, a Delaware
corporation, on the one hand, and SMITHKLINE BEECHAM plc, an
English corporation ("Purchaser"), on the other hand.
W I T N E S S E T H :
WHEREAS, Seller is indirectly the record and
beneficial owner of all of the issued and outstanding shares
of common stock of Sterling Winthrop Inc., a Delaware
corpora- tion ("Sterling");
WHEREAS, Seller and Sterling have entered into an
Asset Purchase Agreement, dated as of June 22, 1994, with
Sanofi (the "Ethical Asset Purchase Agreement") providing for
the sale by Sterling of the Ethical Transferred Business;
WHEREAS, Seller and Sterling have agreed to transfer
the L&F Transferred Business prior to the Closing and to enter into
the L&F Continuing Services Agreement;
WHEREAS, Seller and Sterling will, to the extent set
forth herein and as otherwise reasonably practicable, complete
the Restructuring prior to the consummation of the transac-
tions contemplated hereby;
WHEREAS, Seller has agreed to manage on behalf of
Sterling environmental remediation of certain sites and
certain other environmental and other contingent liabilities
and to indemnify Purchaser for all liabilities and expenses
33
(including administrative expenses), arising out of,
or relating to, such remediation and liabilities; and
WHEREAS, the parties hereto desire that Seller sell
and transfer to Purchaser and Purchaser purchase from Seller
all of the issued and outstanding common stock of Sterling
(the "Shares"), which constitutes all of the outstanding
capital stock of Sterling, upon the terms and conditions set
forth herein;
NOW, THEREFORE, in consideration of the mutual
covenants and undertakings contained herein, and subject to
and on the terms and conditions herein set forth, the parties
hereto agree as follows:
ARTICLE I
DEFINITIONS AND TERMS
Section 1.1 Specific Definitions. As used in this
Agreement, the following terms shall have the meanings set
forth or as referenced below:
"Accounts Payable to Seller" shall mean all U.S. Intercompany
Accounts Payable of the Continuing Business that are
outstanding at any time prior to the Closing to
(x) Seller or (y) a U.S. Affiliate of Seller that does
not constitute part of the Continuing Business.
"Accounts Receivable from Seller" shall mean all U.S.
Intercompany Accounts Receivable of the Continuing
Business that are outstanding at any time prior to the
Closing from (x) Seller or (y) a U.S. Affiliate of Seller
that does not constitute part of the Continuing Business.
"Adjusted Closing Balance Sheet" shall have the meaning set
forth in Section 2.2(b).
34
"Affiliate" shall mean, with respect to any Person, any
Person
directly or indirectly controlling, controlled by, or
under common control with, such other Person at any time
during the period for which the determination of
affiliation is being made.
"Affiliate of Seller" shall refer to one or more Affiliates of
Seller designated by Seller to acquire certain assets and
assume certain liabilities of Sterling as contemplated in
Sections 2.2, 5.9, 5.10 and 5.12 hereof.
"Agreement" shall mean this Agreement, as the same may be
amended or supplemented from time to time in accordance
with the terms hereof.
"Balance Sheet" shall mean the unaudited pro forma consoli-
dated balance sheet of the Continuing Business at
December 31, 1993, which is attached as
Schedule 3.8(a)(i) hereto, including the notes thereto
and information relating thereto set forth in
Schedule 3.8(a)(ii) hereto.
"Benefit Plans" shall have the meaning set forth in
Section 3.11(a).
"Books and Records" shall mean all books, ledgers, files,
reports, plans and operating records of, or maintained
by, the Continuing Business (it being understood that,
pursuant to the Restructuring, originals of certain of
such items maintained by, but not primarily related to,
the Continuing Business may be transferred, in which
case, Books and Records shall refer to copies of such
items).
"Business Day" shall mean any day other than a Saturday, a
Sunday or a day on which banks in New York City are
authorized or obligated by law or executive order to
close.
"Chosen Courts" shall have the meaning set forth in Section
9.11.
"Claim Notice" shall have the meaning set forth in Sec-
tion 7.4.
"Closing" shall mean the closing of the transactions contem-
plated by this Agreement.
"Closing Balance Sheet" shall have the meaning set forth in
Section
2.2(a).
35
"Closing Date" shall have the meaning set forth in Sec-
tion 2.3(a).
"Code" shall mean the Internal Revenue Code of 1986, as
amended.
"COLI" shall mean the corporate-owned life insurance of
Sterling.
"Competition Laws" shall mean statutes, rules, regulations,
orders, decrees, administrative and judicial doctrines,
and other laws that are designed or intended to prohibit,
restrict or regulate actions having the purpose or effect
of monopolization or restraint of trade.
"Confidentiality Agreement" shall mean the Agreement, dated
May 26, 1994 between Purchaser and Seller.
"Consumer Health Business" shall mean the Consumer Health
Group of Sterling as described in all material respects
in the Confidential Memorandum, dated May 1994, provided
to Purchaser.
"Continuing Business" shall mean that portion of the business
of Sterling that would continue if the Restructuring were
given effect at the date hereof.
"Contracts" shall mean any agreements, contracts, mortgages,
bonds, notes, indentures, leases, purchase orders,
arrangements, commitments and licenses, whether written
or oral.
"CPA Firm" shall have the meaning set forth in Section 2.2(b).
"Current Assets" shall mean all current assets of the Continu-
ing Business, other than (i) cash (including any Puerto
Rican Cash), (ii) short-term investments and
(iii) Accounts Receivable from Seller.
"Current Liabilities" shall mean all current liabilities of
the Continuing Business other than (i) short-term
indebtedness for money borrowed, (ii) Accounts Payable to
Seller and (iii) accrued and unpaid U.S. Federal, state
and local income Taxes with respect to the taxable
periods or portions thereof, ending on the close of
business on the Closing Date.
"Disclosed OTC Environmental Liabilities" shall mean
liabilities of the Continuing Business under any
Environmental Law in respect of the items listed on
Schedule 7.3(a)(i) hereto (it being understood solely
for
36
purposes of clarification that Disclosed OTC Environmental
Liabilities excludes any item listed on Schedule 5.13(a)).
"Due Date" shall mean, with respect to any Tax Return, the
date such return is due to be filed (taking into account
all applicable extensions).
"Employees" shall mean all current employees of Sterling and
its Subsidiaries employed in the Continuing Business and
all former employees of Sterling, its predecessors and
their respective subsidiaries who, immediately prior to
the time they ceased to be employees of any such entity,
were employed in the Continuing Business.
"Encumbrances" shall mean liens (including any liens for
Taxes), charges, encumbrances, security interests,
options, or any other restrictions or third party rights.
"Enhanced Pension Letter Agreements" shall mean the Enhanced
Pension Letter Agreements referred to on Sched-
ule 3.11(a).
"Environmental Law" shall mean any applicable federal, state,
local or foreign law, statute, ordinance, rule,
regulation, code, order, judgment, decree or injunction
(other than any Tax Laws) relating to (x) the protection
of the environment (including, without limitation, air,
water vapor, surface water, groundwater, drinking water
supply, surface or subsurface land), (y) occupational
safety and health to the extent it relates to exposure to
Hazardous Substances or (z) the exposure to, or the use,
storage, recycling, treatment, generation,
transportation, processing, handling, labelling,
protection, release or disposal of, radioactive materials
or Hazardous Substances.
"ERISA" shall mean the Employee Retirement Income Security Act
of 1974, as amended.
"ERISA Affiliate" shall have the meaning set forth in Section
3.11(c).
"Estimated Residual Cash Amount" shall mean Seller's estimate
of the Residual Cash Amount to be delivered to Purchaser
pursuant to Section 2.3(b).
"Ethical Asset Purchase Agreement" shall have the meaning set
forth in the Recitals hereto.
37
"Ethical Excluded Assets" shall mean the "Excluded Assets" as
such term is defined in the Ethical Asset Purchase
Agreement.
"Ethical Excluded Liabilities" shall mean the "Excluded
Liabilities" as such term is defined in the Ethical Asset
Purchase Agreement.
"Ethical Transferred Business" shall mean the "Transferred
Business" as such term is defined in the Ethical Asset
Purchase Agreement.
"Exchange Act" shall mean the Securities Exchange Act of 1934,
as amended.
"Financial Statements" shall have the meaning set forth in
Section 3.8(a).
"GAAP" shall mean United States generally accepted accounting
principles.
"Governmental Authorizations" shall mean all licenses,
permits, certificates and other authorizations and
approvals required to carry on the Continuing Business
or, with respect to the Seller, to perform its obliga-
tions under this Agreement, as the case may be, as
currently conducted under the applicable laws, ordinances
or regulations of any Governmental Entity.
"Governmental Entity" shall mean any supranational, national,
federal, state or local judicial, legislative, executive
or regulatory authority.
"Hazardous Substances" shall mean any hazardous substances
within the meaning of 101(14) of CERCLA, 42 U.S.C.
9601(14), or any pollutant or constituent that is regu-
lated under any Environmental Law.
"HSR Act" shall mean the Hart-Scott-Rodino Antitrust Improve-
ments Act of 1976, as amended.
"Indemnified Liability" shall mean a liability of Sterling
that neither arises out of nor is primarily related to
(i) the Consumer Health Business, (ii) activities
relating to headquarters operations, corporate staff of
Sterling and the Consumer Health Group staff of Sterling
located at 90 Park Avenue (including the lease at 90 Park
Avenue), (iii) the assets and liabilities transferred to
Sterling pursuant to the Restructuring, or (iv) the items
listed on Schedule 5.13(a).
38
"Indemnified Parties" shall have the meaning set forth in
Sec-
tion 7.3(a).
"Indemnifying Party" shall have the meaning set forth in Sec-
tion 7.4.
"Intellectual Property" shall mean trademarks, service marks,
brand names, certification marks, trade dress, assumed
names, trade names and other indications of origin, the
goodwill associated with the foregoing and registrations
in any jurisdiction of, and applications in any
jurisdiction to register, the foregoing, including any
extension, modification or renewal of any such
registration or application; inventions, discoveries and
ideas, whether patentable or not in any jurisdiction;
patents, applications for patents (including, without
limitation, divisions, continuations, continuations in-
part and renewal applications), and any renewals,
extensions or reissues thereof, or supplementary patent
certificates derived therefrom, in any jurisdiction; non-
public information, trade secrets and confidential
information and rights in any jurisdiction to limit the
use or disclosure thereof by any Person; writings and
other works, whether copyrightable or not in any
jurisdiction; registrations or applications for
registration of copyrights in any jurisdiction, and any
renewals or extensions thereof; any similar intellectual
property or proprietary rights; technologies, whether
developed or currently under development; and any claims
or causes of action arising out of or related to any
infringement or misappropriation of any of the foregoing.
"Investments" shall have the meaning set forth in Sec-
tion 3.5(a).
"Kodak Transitional Services Agreement" shall have the meaning
set forth in Section 5.9(j) hereto.
"L&F Continuing Services Agreements" shall have the meaning
set forth in Section 5.9(i) hereto.
"L&F Purchase Agreement" shall mean the agreement or agree-
ments to be entered into among the purchaser or
purchasers of the L&F Transferred Business, Seller and
the Affiliate of Seller to which the L&F Transferred
Business is transferred pursuant to Section 5.9 hereof.
"L&F Transferred Business" shall mean the business of Sterling
conducted by the L&F Products division of Sterling and
the assets and liabilities primarily related thereto
(including the manufacturing, marketing, sales,
39
distribution, support operations and research and
development activities primarily related thereto and all
inventories and other assets and liabilities of such
business).
"Laws" shall include any federal, state, foreign or local law,
statute, ordinance, rule, regulation, order, judgment or
decree.
"Losses" shall have the meaning set forth in Section 7.2.
"Material Adverse Change" shall mean a change that has had a
Material Adverse Effect.
"Material Adverse Effect" shall mean an effect that is materi-
ally adverse to the value or the business, results of
operations, financial condition or prospects of the
Continuing Business taken as a whole, but shall exclude
any change or development (x) involving a prospective
change arising out of any proposed or adopted national
healthcare legislation, or any other proposal or
enactment by any governmental or regulatory authority, in
any case similarly affecting the pharmaceutical industry
generally or (y) reflected on Schedule 1.1.
"Nanoparticulate Business Unit" shall mean the nanoparticulate
technology owned or used by Sterling, including all
related Intellectual Property primarily relating thereto,
and all facilities, equipment and other assets of
Sterling primarily relating to the research, development
and production of nanoparticulates (together with all
liabilities primarily relating thereto).
"Net Working Capital" shall mean (x) Current Assets minus
(y) Current Liabilities.
"Nonmedical Leave" shall mean maternity or paternity leave,
leave under the Family and Medical Leave Act of 1993,
educational leave, military leave with veteran's reem-
ployment rights under federal law, or personal leave
(unless any of such is determined to be a medical leave).
"Notice Period" shall have the meaning set forth in Sec-
tion 7.4.
"OTC Portion" shall have the meaning assigned to such term in
the Ethical Asset Purchase Agreement.
"OTC Products Liability" shall mean all products liability
(whether in contract, tort, strict liability or
otherwise) of the Continuing Business (other than any
40
liability constituting an Indemnified Liability) arising
out of the manufacture or sale prior to the Closing by
the Continuing Business of any particular item or
product.
"OTC Venture" shall have the meaning assigned to such term in
the Ethical Asset Purchase Agreement.
"Pension Plan" shall have the meaning set forth in Sec-
tion 3.11(b).
"Permitted Encumbrances" shall have the meaning set forth in
Section 3.16(a).
"Person" shall mean an individual, a corporation, a partner-
ship, an association, a trust or other entity or
organization.
"Plans" shall have the meaning set forth in Section 3.11(b).
"Policies" shall have the meaning set forth in Section 3.20.
"Pre-Alliance Period" shall mean, with respect to each asset
constituting part of the OTC Portion, the period prior to
the date on which such asset was contributed to the OTC
Venture.
"Prime Rate" shall mean the annual rate of interest as
announced by Citibank, N.A. as its prime rate of interest
in effect on the Closing Date for the purpose of
determining the interest rates charged by it for United
States dollar commercial loans made in the United States.
"Puerto Rican Cash" shall mean the assets of Sterling
Pharmaceuticals Inc. that are subject to the terms of
Section 2.4.
"Puerto Rico Pension Plan" shall have the meaning set forth in
Section 5.5(d).
"Purchase Price" shall have the meaning set forth in Sec-
tion 2.1.
"Purchaser" shall have the meaning set forth in the recitals.
"Purchaser Indemnified Parties" shall have the meaning set
forth in Section 7.3(a).
"Recipient" shall have the meaning set forth in Sec-
tion 5.4(f).
41
"Requested Amount" shall have the meaning set forth in Sec-
tion 5.4(d)(iv).
"Required Approvals" shall mean all authorizations, consents,
orders or approvals of, permits or licenses from, or
declarations or filings with any Governmental Entity, and
all third party consents, in each case necessary to
effect the transactions contemplated by this Agreement in
all material respects and to conduct the Continuing
Business as previously conducted in all material
respects.
"Residual Cash Amount" shall mean (x) the sum of (i) cash,
(ii) short-term investments (in the case of each of (i)
and (ii), other than any Puerto Rican Cash) (iii) the
gross cash value of COLI and (iv) the amount paid by
Sterling in respect of Stay Bonuses (net of any tax
savings realized in respect thereof), minus (y) the sum
of (i) indebtedness and (ii) borrowings against COLI, and
(iii) 65% of the Specified Long-Term Obligations, in each
case as derived from the Closing Balance Sheet or the
Adjusted Closing Balance Sheet, as the case may be.
"Restructuring" shall refer to the following transactions: (i)
the transactions contemplated by the Ethical Asset
Purchase Agreement; (ii) the transfer or sale by Sterling
of the L&F Transferred Business and Sterling's entering
into the Kodak Transitional Services Agreements and the
L&F Continuing Services Agreements, all as described in
Section 5.9 hereof; (iii) the sale or transfer of the UPT
Facility and Sterling's Nanoparticulate Business Unit as
described in Section 5.9 hereof; (iv) the acquisition by
one or more Affiliates of Seller of certain assets of
Sterling and the assumption by one or more Affiliates of
Seller of certain liabilities of Sterling as set forth in
Section 5.10 hereof; (v) the disposition of Sterling's
Phisoderm business in the United States, Canada and
Puerto Rico; (vi) the adoption by Sterling of the
Enhanced Pension Letter Agreements; (vii) the transfer to
Seller or an Affiliate of Seller of the proceeds in
respect of the transactions described in clauses (i),
(ii), (iii) and (v); (viii) the transfer to Seller or an
Affiliate of Seller of certain Employees of Sterling as
provided in Section 5.12 hereof; (ix) the cancellation or
settlement of all Accounts Payable to Seller and Accounts
Receivable from Seller; and (x) the transactions and
information contemplated by Section 2.4 hereof.
"Retirement Plan Employees" shall have the meaning set forth
in Section 5.5(b)(ii).
42
"Royal Insurance Litigation" shall mean the Royal Insurance
Litigation set forth on Schedule 3.9(a).
"Sanofi" shall mean Sanofi, a societe anonyme organized under
the laws of the Republic of France.
"Savings Plan Employees" shall have the meaning set forth in
Section 5.5(b)(i).
"Securities Act" shall mean the Securities Act of 1933, as
amended.
"Selected Marks" shall have the meaning set forth in Section
3.13(b)(ii) hereto.
"Seller" shall have the meaning set forth in the recitals.
"Seller Indemnified Parties" shall have the meaning set forth
in Section 7.2.
"Seller Retirement Plan" shall have the meaning set forth in
Section 5.5(b)(ii).
"Seller Savings Plan" shall have the meaning set forth in
Section 5.5(b)(i).
"Seller's Objection" shall have the meaning set forth in
Section 2.2(b).
"Settlement Payment" shall have the meaning set forth in
Section 5.4(d)(iv).
"Shared Intellectual Property" shall have the meaning assigned
thereto in the Ethical Asset Purchase Agreement.
"Shares" shall have the meaning set forth in recitals hereto.
"Specified Long-Term Obligations" shall mean the obligations
of Sterling to Sanofi, pursuant to Section 2.5(c) of the
Ethical Asset Purchase Agreement, and the obligations of
Sterling to the purchaser or purchasers of the L&F
Transferred Business, pursuant to the L&F Purchase
Agreement, in respect of the Sterling Winthrop Inc.
Deferred Compensation Plan (currently estimated to be
$23.0 million in the aggregate) and $1.6 million in
respect of the Sterling Winthrop Inc. Affiliates Phantom
Stock Appreciation Rights Plan in respect of specified
active employees of Sterling.
43
"Stay Bonuses" shall mean bonuses to be paid to certain
employees of Sterling pursuant to the agreements listed
on Schedule 3.11(a).
"Sterling" shall have the meaning set forth in the recitals
hereto.
"Subsidiaries" shall mean the Investments as to which Sterling
owns, directly or indirectly, or otherwise controls, 50%
or more of the voting shares or other similar interests
after giving effect to the Restructuring.
"Tax Audit" shall have the meaning set forth in
Section 5.4(f).
"Tax Item" shall mean, with respect to Taxes, any item of
income, gain, deduction, loss or credit or any other tax
attribute.
"Tax Law" shall mean any Law relating to Taxes.
"Tax Package" shall have the meaning set forth in
Section 5.4(e)(i).
"Tax Returns" shall mean all reports and returns required to
be filed with respect to Taxes.
"Taxes" shall mean all federal, state, local or foreign taxes,
including, but not limited to, income, gross receipts,
windfall profits, alternative minimum, value added,
severance, property, production, sales, use, license,
excise, franchise, employment, withholding or similar
taxes, together with any interest, additions or penalties
with respect thereto and any interest in respect of such
additions or penalties.
"Transfer Taxes" shall have the meaning set forth in Sec-
tion 5.4(g).
"Transferee Pension Plan" shall have the meaning set forth in
Section 5.5(b)(ii).
"Transferee Savings Plan" shall have the meaning set forth in
Section 5.5(b)(i).
"Transferred Businesses" shall mean the entities, assets and
liabilities to be transferred out of Sterling or its
Affiliates or sold by Seller, Sterling or the Affiliates
of either of them, in either case pursuant to the
Restructuring.
44
"Undisclosed OTC Environmental Liabilities" shall
mean
liabilities of the Continuing Business under
Environmental Laws arising from conditions or
circumstances existing as of the Closing Date, other than
routine expenses incurred after the Closing Date in the
ordinary course of business consistent with historical
practice required to maintain compliance with
Environmental Laws, that were not disclosed on Sched-
ule 7.3(a)(i) hereto (other than an Unknown OTC
Environmental Liability). Items disclosed on
Schedule 5.13(a) shall be deemed not to be Undisclosed
OTC Environmental Liabilities.
"Unknown OTC Environmental Liabilities" shall mean liabilities
of the Continuing Business under Environmental Laws
arising from conditions or circumstances of which Seller
did not have knowledge as of the date hereof and shall
exclude each Disclosed OTC Environmental Liability,
Indemnified Liability and item disclosed on Schedule
5.13(a). For purposes of this paragraph, "knowledge"
means the actual knowledge of employees of Seller and
Sterling charged with environmental matters.
"UPT Facility" shall mean Sterling's facility known as the UPT
facility located in Upper Providence Township,
Pennsylvania, and the assets and liabilities primarily
related thereto.
"U.S. Affiliate of Seller" shall mean any Affiliate of Seller
(other than Sterling Pharmaceuticals, Inc.) incorporated
in a jurisdiction located in the United States (other
than Puerto Rico).
"U.S. Antitrust Laws" shall mean and include the Sherman Act,
as amended, the Clayton Act, as amended, the HSR Act, the
Federal Trade Commission Act, as amended, and all other
federal and state statutes, rules, regulations, orders,
decrees, administrative and judicial doctrines, and other
laws that are designed or intended to prohibit, restrict
or regulate actions having the purpose or effect of
monopolization or restraint of trade.
"U.S. Intercompany Accounts Payable of the Continuing
Business" shall mean accounts payable of the Continuing
Business that arise out of the portions of the Continuing
Business conducted in the United States.
"U.S. Intercompany Accounts Receivable of the Continuing
Business" shall mean accounts receivable of the
Continuing Business that arise out of the portions of the
Continuing Business conducted in the United
States.
45
"WARN" shall mean the Worker Adjustment and Retraining Notifi-
cation Act.
Section 1.2 Other Terms. Other terms may be
defined elsewhere in the text of this Agreement and, unless
otherwise indicated, shall have such meaning throughout this
Agreement.
Section 1.3 Other Definitional Provisions.
(a) The words "hereof", "herein", and "hereunder"
and words of similar import, when used in this Agreement,
shall refer to this Agreement as a whole and not to any parti-
cular provision of this Agreement.
(b) The terms defined in the singular shall have
a comparable meaning when used in the plural, and vice versa.
(c) The terms "dollars" and "$" shall mean United
States dollars.
ARTICLE II
PURCHASE OF COMMON STOCK
Section 2.1 Purchase and Sale of Common Stock. On
the terms and subject to the conditions set forth herein, at
the Closing, Seller agrees to cause 343 Holding Corporation,
and 343 Holding Corporation agrees, to sell and transfer to
Purchaser, and Purchaser agrees to purchase from 343 Holding
Corporation and Seller, the Shares, for an aggregate purchase
price of $2,925,000,000 (the "Purchase Price") subject to
adjustment as provided in Section 2.3 hereof.
46
Section 2.2 Post-Closing Adjustments.
(a) Within 45 days following the Closing, Purchaser
shall prepare, or cause to be prepared, and deliver to
Seller a Closing Date consolidated balance sheet (the
"Closing Balance Sheet"), which shall set forth the assets and
liabili- ties of the Continuing Business as of the Closing
Date and shall be prepared substantially in accordance with
the principles and methods set forth in Schedule 3.8(a)(ii)
applied on a basis consistent with the Balance Sheet. In no
event will purchase accounting adjustments relating to the
purchase of the Shares or the Restructuring be made to the
Closing Balance Sheet. The parties acknowledge that if any
portion of the Restructuring has not been completed at the
time of the Closing, the Closing Balance Sheet will be
prepared on a pro forma basis as if the Restructuring had
been completed at such time.
(b) Seller and Seller's accountants shall, within
20 days after the delivery by Purchaser of the Closing Balance
Sheet, complete their review of (i) the Residual Cash Amount
and (ii) Net Working Capital, in each case derived from the
Closing Balance Sheet. In the event that Seller determines
that the Residual Cash Amount or Net Working Capital, as
derived from the Closing Balance Sheet, has not been deter-
mined on the basis set forth in Section 2.2(a) hereof, Seller
shall inform Purchaser in writing (the "Seller's Objection"),
setting forth a specific description of the basis of Seller's
47
Objection and the adjustments to the Residual Cash Amount or
Net Working Capital which Seller believes should be made, on
or before the last day of such 20-day period. Purchaser shall
then have 20 days to review and respond to Seller's
Objection. If Purchaser and Seller are unable to resolve all
of their disagreements with respect to the determination of
the foregoing items within 10 days following the completion of
Purchaser's review of Seller's Objection, they shall refer
their remaining differences to Arthur Andersen or another
internationally recognized firm of independent public
accountants as to which Seller and Purchaser mutually agree
(the "CPA Firm"), who shall, acting as experts and not as
arbitrators, determine on the basis of the standard set forth
in Section 2.2(a) hereof, and only with respect to the
remaining differences so submitted, whether and to what
extent, if any, the Residual Cash Amount or Net Working
Capital, as derived from the Closing Balance Sheet, requires
adjustment. The parties shall instruct the CPA Firm to
deliver its written determination to Purchaser and Seller no
later than the twentieth day after the remaining differences
underlying the Seller's Objection are referred to the CPA
Firm. The CPA Firm's determination shall be conclusive and
binding upon Purchaser and Seller. The fees and disbursements
of the CPA Firm shall be shared equally by Purchaser and
Seller. Purchaser and Seller shall (and Purchaser shall cause
Sterling to) make readily available to the CPA Firm all
48
relevant books and records and any work papers (including
those of the parties' respective accountants) relating to the
Balance Sheet and the Closing Balance Sheet and all other
items reasonably requested by the CPA Firm. The "Adjusted
Closing Balance Sheet" shall be (i) the Closing Balance Sheet
in the event that (x) no Seller's Objection is delivered to
Purchaser during the 20-day period specified above or
(y) Seller and Purchaser so agree, (ii) the Closing Balance
Sheet, adjusted in accordance with the Seller's Objection, in
the event that Purchaser does not respond to Seller's
Objection within the 20-day period following receipt by
Purchaser of Seller's Objection, or (iii) the Closing Balance
Sheet, as adjusted by either (x) the agreement of Seller and
Purchaser or (y) the CPA Firm. In the event that the adjust-
ment of the Closing Balance Sheet pursuant to this Section
2.2(b) discloses that it is appropriate to include an item in
the calculation of Net Working Capital that had been omitted
from the Closing Balance Sheet or to omit an item in the
calculation of Net Working Capital that had been included in
the Closing Balance Sheet, Purchaser shall prepare a revised
Balance Sheet including or omitting such item, as the case
may be, as at the date thereof.
(c) Purchaser shall, and shall cause Sterling to,
provide Seller and its accountants (i) all data and financial
statements reasonably requested by Seller and (ii) full access
to the Books and Records, any other information, including
49
work papers of its accountants, and to any employees to the
extent necessary for Seller to review the Closing Balance
Sheet and the Adjusted Closing Balance Sheet.
(d) Within five Business Days following issuance of
the Adjusted Closing Balance Sheet, the adjustment payments
payable pursuant to this Section 2.2(d) shall be paid by wire
transfer of immediately available funds to a bank account
designated by Purchaser or Seller, as the case may be,
together with interest thereon at the Prime Rate from and
including the Closing Date to but not including the date of
payment. Purchaser or Seller, as the case may be, shall make
adjustment payments in respect of Net Working Capital in an
amount equal to the difference between: (x) Net Working
Capital as derived from the Balance Sheet and (y) Net Working
Capital as derived from the Adjusted Closing Balance Sheet.
The adjustment payment in respect of Net Working Capital will
be made by Seller to Purchaser to the extent that Net Working
Capital as derived from the Adjusted Closing Balance Sheet is
less than Net Working Capital as derived from the Balance
Sheet and by Purchaser to Seller to the extent that Net
Working Capital as derived from the Adjusted Closing Balance
Sheet is greater than Net Working Capital as derived from the
Balance Sheet. Purchaser or Seller, as the case may be,
shall
50
make adjustment payments in respect of residual cash in an
amount equal to the difference between: (x) the Estimated
Residual Cash Amount and (y) the Residual Cash Amount. The
adjustment payment in respect of residual cash will be made by
Seller to Purchaser to the extent that the Residual Cash
Amount is less than the Estimated Residual Cash Amount and by
Purchaser to Seller to the extent that the Residual Cash
Amount is greater than the Estimated Residual Cash Amount.
Section 2.3 Closing; Delivery and Payment.
(a) The Closing shall take place at the offices of
Sullivan & Cromwell, 125 Broad Street, New York, New York 10004 at
10:00 A.M. New York City time, on the later of (i) October
15, 1994, or (ii) 10 Business Days after the closing of the
transactions under the Ethical Asset Purchase Agreement, in
either event only if all of the conditions precedent
specified in Article VI have been satisfied or waived;
provided that in any event the Closing shall occur no later
than November 30, 1994; or at such other time and place as
the parties hereto may mutually agree. The date on which the
Closing occurs is called the "Closing Date".
(b) No later than five Business Days prior to the
Closing Date, Seller shall deliver to Purchaser Seller's
determination of the Estimated Residual Cash Amount.
(c) On the Closing Date, Seller shall cause 343
Holding Corporation, and 343 Holding Corporation shall,
deliver to Purchaser certificates representing the Shares
duly
51
endorsed and in form for transfer to Purchaser, and Purchaser
shall pay to Seller (i) the Purchase Price for the Shares and
(ii) the Estimated Residual Cash Amount in immediately
available funds to an account designated by Seller not less
than two Business Days prior to the Closing.
Section 2.4 Puerto Rican Cash.
(a) On the Closing Date, Sterling will own all of
the stock of Sterling Pharmaceuticals Inc. ("SPI"), a
corporation formed under the laws of the State of Arkansas
which is a "936 corporation" within the meaning of section
936 of the Code. As of the date of this Agreement, SPI has
agreed to invest $126,718,823 (the "Invested Amount") pursuant
to certain restrictions which have entitled, and, in the
future, will entitle SPI to the benefit of reduced Puerto
Rican tollgate taxes upon the distribution of the Invested
Amount. If the entire Invested Amount is distributed in the
future in a manner that reflects the aforementioned
restrictions, the distributions will be subject to a tollgate
tax of $4,127,443. If the Invested Amount were distributed
prematurely, SPI would be subject to Puerto Rican tollgate tax,
recapture tax, recapture surcharge and recapture interest in
the amount of $39,175,289, an increase of $35,047,846. The
amounts set forth in this Section 2.4(a) are set forth in
greater detail on Schedule 2.4(a).
(b) For its fiscal year ending October 31, 1993,
SPI earned $65,820,000 which SPI will distribute to Sterling
52
between the date of this Agreement and the Closing Date,
subject to a 10 percent Puerto Rican tollgate tax.
(c) For its fiscal year ending October 31, 1994,
(the "1994 Year"), SPI expects to earn approximately $75
million. SPI plans to invest such portion (one-half under
current Puerto Rican law) of the actual amount it earns for
the 1994 Year (the "1994 Invested Amount") in a manner and
for such period (currently five years) that will permit SPI to
distribute the total 1994 earnings subject to a reduced Puerto
Rican tollgate tax.
(d) The Seller and Purchaser agree that neither the
Purchase Price nor any adjustment thereto is intended to
compensate Seller for the Invested Amount and the 1994
Invested Amount owned by SPI, and Seller and Purchaser agree
that they will act together to preserve the value of such
investments for Seller as if Seller retained ownership of
Sterling and SPI distributed to Sterling the Invested Amount
and the 1994 Invested Amount in a manner that limits the
Puerto Rican tollgate tax on the Invested Amount to
$4,127,443 and on the 1994 Invested Amount to that tollgate
rate which would be applicable to a distribution of the 1994
Invested Amount if that amount is invested as provided in
Section 2.4(c). In the case of the Invested Amount, the
availability of distributions which will limit the tollgate
tax to $4,127,443 is set forth on Schedule
2.4(d).
53
(e) For the purpose of implementing the goal stated
in Section 2.4(d), Purchaser will cause SPI to invest and
reinvest its assets in a manner that will achieve such goal
and will cause SPI to pay directly to Seller as additional
purchase price such maximum portions of the Invested Amount as
may be distributed in accordance with Schedule 2.4(d) and such
maximum portions of the 1994 Invested Amount as may be
distributed without increasing the otherwise applicable
minimum Puerto Rican tollgate tax, in each case, net of the
tollgate tax and any other Taxes for which Seller has agreed
to indemnify the Purchaser Indemnified Parties pursuant to
Section 5.4(b) hereof, and, in addition, to pay to Seller as
additional purchase price any remaining assets of SPI, net of
applicable Puerto Rican tollgate tax and any other Taxes for
which Seller has agreed to indemnify the Purchaser
Indemnified Parties pursuant to Section 5.4(b) hereof.
(f) Seller shall appoint an individual (including
any successor selected by Seller) who, at Seller's expense,
will be designated as SPI's sole agent, with a power of
attorney that is not revocable by any person other than
Seller, to manage the investments and reinvestment of SPI's
assets in the manner described in this Section 2.4 and to
cause SPI to make payments directly to Seller in the manner
prescribed in this Section 2.4.
(g) Purchaser will not permit Sterling or any other
entity to transfer any assets to, or remove any assets from,
54
SPI, except as permitted under this Section 2.4 and Purchaser
will not permit Sterling to liquidate SPI or transfer SPI
stock to any other person.
(h) The foregoing to the contrary notwithstanding,
Seller will request a ruling or closing agreement from the
Puerto Rican tax authorities that will permit SPI to transfer
all of its assets to Seller or a directly or indirectly
wholly owned subsidiary of Seller without incurring any
greater
Puerto Rican taxes than would be the case if the provisions of
Section 2.4(a) through (g) were implemented as prescribed. In
the event such a ruling or closing agreement is obtained prior
to the Closing Date, Seller will cause SPI to transfer its
assets to Kodak or its designated subsidiary immediately and
Section 2.4(a) through (g) shall become null and void. If the
requested ruling or closing agreement is not obtained prior to
the Closing Date, Seller will be authorized by Purchaser or
SPI, as necessary to continue to seek the requested ruling or
closing agreement and, in the event it is obtained, SPI
immediately thereafter will transfer all of its assets
to Kodak or its designated subsidiary as additional
purchase price and Sections 2.4(a) through (g) shall
thereafter be null and void.
55
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF SELLER
Seller represents and warrants to Purchaser as of
the date hereof and as of the Closing Date (except (i) that
representations and warranties that are made as of a specific
date need be true only as of such date, and (ii) to the
extent any representation or warranty may be deemed to relate
to any item constituting an Indemnified Liability, an OTC
Products Liability, an Undisclosed OTC Environmental
Liability, an Unknown OTC Environmental Liability, or any item
listed on Schedule 5.13(a), as to which no representations
and warranties other then Section 3.22 are made herein) as
follows:
Section 3.1 Organization, Qualification and
Authority of Seller. Each of Seller and 343 Holding
Corporation is a corporation duly organized, validly existing
and in good standing under the laws of the jurisdiction of
its incorporation and has full corporate power and authority
to execute and deliver this Agreement and to perform its
obligations hereunder. The execution, delivery and performance
by Seller and 343 Holding Corporation of this Agreement has
been duly and validly authorized by Seller and 343 Holding
Corporation and, subject to obtaining the approval of the
Board of Directors of Seller, no other corporate proceedings
on the part of Seller, 343 Holding Corporation or any of
their Affiliates are necessary in connection with the
execution,
56
delivery and performance by Seller and 343 Holding Corporation
of this Agreement.
Section 3.2 Binding Effect. This Agreement has
been duly and validly executed and delivered by Seller and 343
Holding Corporation and constitutes a valid and legally
binding obligation of Seller and 343 Holding Corporation
enforceable against Seller and 343 Holding Corporation in
accordance with its terms.
Section 3.3 Organization, Qualification and
Authority of Sterling. Sterling is a corporation duly organ-
ized, validly existing and in good standing under the laws of
the jurisdiction of its incorporation and has all requisite
corporate power and authority to own its assets and to carry
on its business as currently conducted. Except as set forth
on Schedule 3.3 hereto, Sterling is duly qualified to do
business and is in good standing as a foreign corporation in
each jurisdiction where the ownership or operation of its
assets or the conduct of its business requires such
qualification, except where the failure to be so qualified or
in good stand- ing, as the case may be, would not have a
Material Adverse Effect, can be cured without material expense
and will not result in the unenforceability of any material
Contract. Complete and correct copies of the certificate
of incorporation and by-laws of Seller and Sterling will
be delivered to Purchaser prior to
Closing.
57
Section 3.4 Ownership of Shares. The Shares
constitute all of the issued and outstanding capital stock of
Sterling. There are no other classes of capital stock of
Sterling authorized or outstanding. The Shares are duly
authorized, validly issued, fully paid and non-assessable.
Seller owns all of the outstanding stock of 343 Holding
Corporation. 343 Holding Corporation owns the Shares, of
record and beneficially, free and clear of Encumbrances.
Except for this Agreement, and as set forth on Schedule 3.4
hereto, there are no preemptive or other outstanding rights,
options, warrants, conversion rights or agreements or
commitments of any character relating to Sterling's authorized
and issued, unissued or treasury shares of capital stock, and
Sterling has not issued any debt securities, other securities,
rights or obligations which are convertible into or
exchangeable for, or giving any Person a right to
subscribe for or acquire, capital stock of Sterling, and no
such securities or obligations evidencing such rights are
outstanding.
Section 3.5 Investments; Joint Ventures, etc.
(a) Schedule 3.5(a)(i) hereto sets forth a list of
each corporation and other entity (together, the
"Investments") owned in whole or in part by the Continuing
Business, together with its jurisdiction of organization.
Except as set forth on Schedule 3.5(a)(ii) hereto, each
Investment which is a Subsidiary is a corporation or other
58
entity duly organized, validly existing, and in good standing
under the laws of its jurisdiction of organization and has all
requisite corporate or similar power and authority to own and
operate its properties and assets and to carry on its business
as presently conducted and is duly qualified to do business
and is in good standing as a foreign corporation or other
entity in each jurisdiction where the ownership or operation
of its properties and assets or the conduct of its business
requires such qualification, except where the failure to be
so duly organized, validly existing, qualified or in good
standing would not have a Material Adverse Effect, can be
cured without material expense and will not result in the
unenforceability of any material Contract.
(b) (i) Except as set forth on Schedule 3.5(b)
hereto and except for directors' qualifying shares, Sterling
owns, or will own at the Closing Date, directly or
indirectly, all (or such lesser percentage shown on Schedule
3.5(a)(i)) of the outstanding capital stock or other equity
interest of each Subsidiary, free and clear of all
Encumbrances. There are no preemptive or other outstanding
rights, options, warrants, conversion rights or agreements
or commitments to issue or sell any shares of capital stock
or other equity interest of any such Subsidiary or any
securities, rights or obligations convertible into or
exchangeable for, or giving any Person a right to subscribe
for or acquire, any shares of capital stock or other equity
interest of any such Subsidiary, and no
59
securities or obligations evidencing such rights are
outstand- ing.
(ii) Except as set forth on Schedule 3.5(b) hereto,
Sterling owns, or will own following the closing of the trans-
actions under the Ethical Asset Purchase Agreement, directly
or indirectly, the interest in each Investment which is not a
Subsidiary set forth in Schedule 3.5(a)(i), free and clear of
all Encumbrances. The issued and outstanding shares of capi-
tal stock of each Subsidiary that is a corporation are duly
authorized, validly issued, fully paid and non-assessable.
Section 3.6 Consents and Approvals. Except as spe-
cifically set forth in Schedule 3.6 or as required by
Competition Laws, foreign investment laws, the laws governing
or regulations promulgated by the United States Drug
Enforcement Agency and Bureau of Alcohol and Tobacco of the
United States Department of the Treasury and laws requiring
registration of products for sale, no consent, approval,
waiver or authorization is required to be obtained by Seller,
Sterling or any of the Subsidiaries from, and no notice or
filing is required to be given by Seller, Sterling or any of
the Subsidiaries to or made by Seller, Sterling or any of the
Subsidiaries with, any Governmental Entity or other Person in
connection with the execution, delivery and performance by
Seller of this Agreement, other than where the failure to
have or make any such consent, approval, waiver,
authorization, notice or filing is not
material.
60
Section 3.7 Non-Contravention. Except as set forth
on Schedule 3.7, the execution, delivery and performance by
Seller of this Agreement, and the consummation of the transac-
tions contemplated hereby, does not and will not (i) violate
any provision of the Certificate of Incorporation, Bylaws or
other organizational documents of Seller, Sterling or any of
the Subsidiaries, (ii) subject as to performance to obtaining
the consents referred to in Section 3.6, conflict with, or
result in the breach of, or constitute a default under, or
result in the termination, cancellation or acceleration
(whether after the giving of notice or the lapse of time or
both) of any right or obligation of Seller, Sterling or any of
the Subsidiaries under, or to a loss of any benefit to which
Seller, Sterling or any of the Subsidiaries is entitled under,
any Contract or other instrument to which Seller, Sterling or
any of the Subsidiaries is a party or result in the
creation of any Encumbrance upon any of the Shares, or (iii)
assuming as to performance compliance with the matters set
forth in Sections 3.6 and 4.4, to the knowledge of Seller,
violate or result in a breach of or constitute a default
under any law, rule, regulation, judgment, injunction, order,
decree or other restriction of any court or governmental
authority to which Seller, Sterling or any of the Subsidiaries
is subject, including any Governmental Authorization, other
than in the case of clauses (ii) and (iii), any conflict,
breach, termination, default, cancellation, acceleration,
loss,
61
violation or Encumbrance which, individually or in the
aggregate, would not be material.
Section 3.8 Financial Statements.
(a) The Balance Sheet, including the notes thereto,
fairly presents in all material respects the unaudited
pro forma, consolidated financial condition of the Continuing
Business, as of the date thereof, adjusted to give effect to
the Restructuring, and was prepared in accordance with U.S.
GAAP except as described in Schedule 3.8(a)(ii) hereto. The
unaudited pro forma statements of earnings from operations,
including the notes thereto, for the three months ended
March 31, 1994, and the years ended December 31, 1993 and
1992, attached as Schedule 3.8(a)(i) hereto (together with
the Balance Sheet, the "Financial Statements"), fairly present
in all material respects the consolidated results of
operations of the Consumer Health Business, giving effect to
the pro forma adjustments described in the notes thereto,
for the periods then ended and were prepared as described
in Schedule 3.8(a)(ii) hereto. The notes to the
Financial Statements are true and correct in all material
respects.
(b) Except as disclosed in the notes to the Balance
Sheet, all of the assets and liabilities reflected on the Bal-
ance Sheet at December 31, 1993 were related to the Continuing
Business and arose out of or were incurred in the conduct of
the Continuing
Business.
62
(c) The unaudited financial information set forth
in Schedule 3.8(c)(i) hereto and Schedule 3.8(c)(ii) hereto
has been derived from the managerial accounts of the Consumer
Health Business and fairly presents, in all material
respects, the net sales and earnings from operations of the
Consumer Health Business by geographic region for the years
ended December 31, 1992 and 1993, on a consistent basis, and
the worldwide net sales of the Consumer Health Business by
product category for the years ended December 31, 1992 and
1993, on a consistent basis, respectively.
Section 3.9 Litigation and Claims.
(a) Except as set forth in Schedule 3.9(a), there
is no civil, criminal or administrative action, suit, demand,
claim, hearing, proceeding or investigation pending or, to
the knowledge of Seller, threatened, involving the Continuing
Business other than those that individually would not reason-
ably be expected to result in a judgment of more than
$1 million or that would be, in the aggregate, material or
materially impair or delay Seller's ability to effect the
Closing.
(b) Except as set forth in Schedule 3.9(b), the
Continuing Business is not subject to any order, writ,
judgment, award, injunction, or decree of any court or govern-
mental or regulatory authority of competent jurisdiction or
any arbitrator or arbitrators other than those that, individu-
ally or in the aggregate, would not materially interfere with
63
Sterling's ability to conduct the Continuing Business
substan- tially as conducted on December 31, 1993 or
materially impair or delay the ability of Seller to effect the
Closing. The Continuing Business is not in violation of any
such material order, writ, judgment, award, injunction or
decree that is material.
Section 3.10 Taxes. Except as set forth in Sched-
ule 3.10 and except as such failure of any representation made
in this Section 3.10 to be true and correct which, when taken
in the aggregate with all other such failures (regarding the
representations made in this Section 3.10 only), would not
have a Material Adverse Effect, taking into consideration any
obligation of Seller to indemnify the Purchaser Indemnified
Parties under this Agreement;
(a) All Tax Returns that are required to be filed
on or before the date of this Agreement (taking into account
applicable extensions) by or on behalf of Sterling or the
Subsidiaries (without giving effect to the Restructuring)
have been timely filed in the manner prescribed by law; (b)
all Taxes shown to be due on the Tax Returns referred to in
clause (a) have been timely paid or recorded as reserves or
current liabilities on the Balance Sheet, with respect to
periods ending on or prior to December 31, 1993, and in the
Books and Records for periods commencing after December 31,
1993; (c) as of the time of filing, all Tax Returns referred
to in clause (a) were true, correct and complete in accordance
with the
64
governing jurisdictions' Tax Laws; (d) no adjustments or
deficiencies relating to the Tax Returns referred to in clause
(a) have been proposed, asserted or assessed in writing by the
Internal Revenue Service or the appropriate state, local or
foreign taxing authority and each adjustment or deficiency set
forth in Schedule 3.10 is being contested in good faith to the
extent appropriate; (e) there are no pending or, to the
knowledge of Seller, threatened actions or proceedings for the
assessment or collection of Taxes against any entity described
in clause (a) and any actions or proceedings set forth in
Schedule 3.10 are being handled in good faith; (f) there are
no outstanding waivers or agreements extending the applicable
statute of limitations for any period with respect to any
Taxes of any entity described in clause (a); (g) no taxing
authorities are presently conducting any audits or other
examinations of any Tax Returns referred to in clause (a);
(h) there are no written tax sharing agreements to which
Sterling or any Subsidiary is a party other than such
agreements entered into in connection with the
Restructuring; and (i) Sterling's U.S. Federal income tax
returns for the taxable years ending on or before the
acquisition of Sterling by Seller in February, 1988 have
been examined by the Audit Division of the Internal
Revenue
Service.
65
Section 3.11 Employee Benefits.
(a) All benefit plans, contracts or arrangements
covering U.S. Employees, including, but not limited to,
"employee benefit plans" within the meaning of Section 3(3) of
ERISA, and plans of deferred compensation (collectively, the
"Benefit Plans"), are listed in Schedule 3.11(a). True and
complete copies of all Benefit Plans, including, but not
limited to, any trust instruments and insurance contracts
forming a part of any Benefit Plans, and all amendments
thereto have been provided or made available to Purchaser.
(b) All employee benefit plans covering U.S.
Employees (the "Plans"), to the extent subject to ERISA or
the Code, are in substantial compliance with ERISA or the
Code, as the case may be. Each Plan which is an "employee
pension benefit plan" within the meaning of Section 3(2) of
ERISA ("Pension Plan") and which is intended to be qualified
under Section 401(a) of the Code has received a favorable
determination letter from the Internal Revenue Service, and
Seller is not aware of any circumstances likely to result in
revocation of any such favorable determination letter. Except
as set forth in Schedule 3.11(b), there is no material pending
or threatened litigation relating to the Plans. Neither
Sterling nor any of its Subsidiaries has engaged in a
transaction with respect to any Plan that, assuming the
taxable period of such transaction expired as of the date
hereof, could subject Sterling or any Subsidiary to a tax or
66
penalty imposed by either Section 4975 of the Code or
Section 502(i) of ERISA in an amount which would be material.
(c) No liability under Subtitle C or D of Title IV
of ERISA has been or is expected to be incurred by Sterling or
any of the Subsidiaries with respect to any ongoing, frozen or
terminated "single-employer plan", within the meaning of Sec-
tion 4001(a)(15) of ERISA, currently or formerly maintained by
any of them, or the single-employer plan of any entity which
is considered one employer with Sterling under Section 4001 of
ERISA or Section 414 of the Code (an "ERISA Affiliate").
Sterling and its Subsidiaries have not incurred and do not
expect to incur any withdrawal liability with respect to a
multiemployer plan under Subtitle E of Title IV of ERISA.
Sterling and its Subsidiaries do not now participate in,
contribute to, or have an obligation to contribute to, and
within the preceding six years have not participated in,
contributed to or been required to contribute to, a
multiemployer plan within the meaning of Section 3(37) of
ERISA. No notice of a "reportable event", within the
meaning of Section 4043 of ERISA for which the 30-day
reporting requirement has not been waived, has been required
to be filed for any Pension Plan or by any ERISA Affiliate
within the 12- month period ending on the date hereof.
(d) Neither any Pension Plan nor any single-
employer plan of an ERISA Affiliate has an "accumulated
funding deficiency" (whether or not waived) within the
meaning
67
of Section 412 of the Code or Section 302 of ERISA and neither
Sterling nor any ERISA Affiliate has an outstanding funding
waiver. Neither Sterling nor any of the Subsidiaries has
provided, or is required to provide, security to any Pension
Plan or to any single-employer plan of an ERISA Affiliate
pursuant to Section 401(a)(29) of the Code.
(e) Under each Pension Plan which is a single-
employer plan, as of the last day of the most recent plan year
ended prior to the date hereof, the actuarially determined
present value of all "benefit liabilities", within the meaning
of Section 4001(a)(16) of ERISA (as determined on the basis of
the actuarial assumptions contained in the Plan's most recent
actuarial valuation), did not exceed the then current value of
the assets of such Plan, and there has been no material change
in the financial condition of such Plan since the last day of
the most recent plan year.
(f) Neither Sterling nor any of the Subsidiaries
has any obligations for retiree health and life benefits under
any Benefit Plan, except as set forth on Schedule 3.11(f).
(g) All employee benefit plans, contracts or
arrangements covering non-U.S. Employees comply in all
material respects with applicable local law. Except as set
forth on Schedule 3.11(g), Sterling and the Subsidiaries have
no material unfunded liabilities with respect to any "employee
pension benefit plan" within the meaning of Section 3(2) of
ERISA which covers non-U.S.
Employees.
68
Section 3.12 Compliance with Laws. Except as set
forth in Schedule 3.12 hereto, the Continuing Business is
being conducted in compliance with all applicable laws, rules
and regulations, except where the failure so to comply,
individually or in the aggregate, would not be material;
Sterling and the Subsidiaries have all Governmental Authori-
zations necessary for the conduct of the Continuing Business
as currently conducted, other than those the absence of which
would not be material; and there are no proceedings pending
or, to the knowledge of Seller, threatened which may result
in the revocation, cancellation or suspension of any such
Govern- mental Authorization except Governmental
Authorizations the absence of which would not be material; it
being understood that nothing in this representation is
intended to address any compliance issue that is the subject
of any other representa- tion or warranty set forth herein.
Section 3.13 Intellectual Property.
(a) Schedule 3.13(a) sets forth a list and brief
description (including where applicable the registration
number and country of registration or filing) of (i) all
patents, patent applications, designs, registered trademarks,
trademark applications, copyright registrations and copyright
applications related to the Continuing Business that are
owned by Sterling or the Subsidiaries and (ii) all agreements
under which Sterling or the Subsidiaries are licensed or
otherwise permitted to use patents, trademarks and copyrights
which are
69
material to the Continuing Business. The sale of the Shares
to Purchaser will not result in the termination of Sterling's
rights with respect to any material item of Intellectual
Property listed on Schedule 3.13(a).
(b) To the knowledge of the Seller (i) except as
set forth in Schedule 3.13(b)(i), with respect to
Intellectual Property of the Continuing Business other than
trademarks, no product or product under development (or
component thereof or process) used, sold or manufactured by
the Continuing Business infringes on or otherwise violates the
valid and enforceable patents of any other Person or were
acquired or developed with the aid of any information obtained
or disclosed in violation of any confidentiality obligation
enforceable against Sterling or the breach of which could
result in Losses to Sterling, (ii) with respect to the
trademarks listed in Schedule 3.13(b)(ii) (the "Selected
Marks"), except as set forth in Schedule 3.13(b)(iii), there
are no restrictions that would materially impair the use of
the Selected Marks in connection with the Continuing Business
and the Selected Marks do not infringe upon or otherwise
violate the valid trademarks of any other Person, (iii) no
Person is challenging or, to the knowledge of Seller,
infringing or otherwise violating or threatening to challenge,
infringe or violate the Intellectual Property of the
Continuing Business or Shared Intellectual Property (excluding
trademarks included on
Schedule 3.13(b)(ii)), except in each case for challenges,
70
infringements or violations, that individually or in the
aggregate, would not materially interfere with Sterling's
ability to conduct the Continuing Business substantially as
heretofore conducted and (iv) there are no oppositions,
revocations, reexaminations, nullity actions or the like which
are pending or threatened against the Sterling Intellectual
Property.
Section 3.14 Labor Matters; Collective Bargaining
Agreements. Except as set forth in Schedule 3.14 hereto,
there is no unfair labor practice charge or complaint or other
proceeding pending or, to the knowledge of Seller, threatened
against Sterling or the Subsidiaries or relating to the
Continuing Business before the National Labor Relations Board
or any other United States Governmental Entity. There is no
material labor strike, slowdown or stoppage pending or, to the
knowledge of Seller, threatened against or affecting Sterling,
any Subsidiary or the Continuing Business, nor has there been
any such activity within the past three years. There are no
currently on-going collective bargaining negotiations relating
to the employees of the Continuing Business.
Section 3.15 Contracts. Schedule 3.15(i) sets
forth a list, as of the date hereof, of each Contract that is
material to the Continuing Business other than (i) purchase
orders in the ordinary course of business consistent with
past practice that are not unusual in nature or amount, and
(ii) any Contract involving the payment of less than
$250,000 in
71
the aggregate or with a term of less than one year. Except as
set forth in Schedule 3.15(ii), each material Contract listed
in Schedule 3.15(i) is a valid and binding agreement of
Sterling or one of the Subsidiaries, as the case may be, and
is in full force and effect. Except as otherwise provided in
Schedule 3.15(iii), Sterling (or its Subsidiaries) is not in
material default and Seller has no knowledge of any material
default under any material Contract listed in Schedule
3.15(i) which default has not been cured or waived.
Section 3.16 Title to Property.
(a) Sterling and the Subsidiaries have good (and in
the case of owned real property) marketable title to, or a
valid and binding leasehold interest in, the property and
assets reflected on the Balance Sheet (other than the Intel-
lectual Property subject to Section 3.13(b)), free and clear
of all Encumbrances, except (i) as set forth in Sched-
ule 3.16(a), (ii) any Encumbrances expressly disclosed in the
Financial Statements (including the notes thereto),
(iii) liens for Taxes, assessments and other governmental
charges not yet due and payable or due but not delinquent or
being diligently contested in good faith by appropriate
proceedings with respect to amounts that are not individually
or in the aggregate material or with respect to which
appropriate reserves have been accrued, (iv) mechanics',
workmen's, repairmen's, warehousemen's, carriers' or other
like liens arising or incurred in the ordinary course of
72
business with respect to amounts that are not individually or
in the aggregate material or with respect to which appropriate
reserves have been accrued, original purchase price condi-
tional sales contracts and equipment leases with third parties
entered into in the ordinary course of business, and
(v) Encumbrances which, individually or in the aggregate,
would not materially impair Sterling's ability to conduct the
Continuing Business substantially as currently conducted (all
items included in (i) through (v), together with any matter
set forth in Schedule 3.16(a), are referred to collectively
herein as the "Permitted Encumbrances").
(b) Each of Sterling and the Subsidiaries owns or
leases and upon consummation of the Restructuring will own or
lease, directly or indirectly, all of the assets and
properties, and is and will be a party to all licenses and
other agreements, in each case which are currently being used
or are reasonably necessary to carry on the business and
operations of the Continuing Business as presently conducted.
(c) Seller makes no representation in this Agree-
ment as to the physical condition or usefulness for any par-
ticular purpose of the real or tangible personal property
constituting part of the Continuing Business.
Section 3.17 Absence of Change. Except (x) to the
extent arising out of or relating to the transactions
contemplated by this Agreement and the Restructuring, or
(y) for the Contracts entered into since December 31, 1993
73
that are listed in Schedule 3.15(i), since December 31, 1993,
(i) the Continuing Business has been operated in the ordinary
course in a manner consistent with past practice; (ii) no
material obligation or liability adverse to the operations,
properties, prospects or affairs of the Continuing Business
has been incurred; (iii) no material assets of the Continuing
Business have been transferred, leased or otherwise disposed
of, mortgaged, pledged or subjected to any security interest;
(iv) no rights of material value have been waived, released
or assigned in connection with the Continuing Business; (v) no
material casualty loss or damage (whether or not such loss or
damage shall have been covered by insurance) which affects in
any material respect the Continuing Business has been
suffered; (vi) no material license, permit, registration or
other approval, authorization or consent from any
Governmental Entity or any other Person relating to the
conduct of the Continuing Business has been terminated or
surrendered; or (vii) no agreement or arrangement to take any
action described in clauses (i) - (vi) of this Section 3.17
has been entered into. Since December 31, 1993 there have not
been any occurrences that have had, or are reasonably likely
to have,
a Material Adverse Effect.
Section 3.18 Finders' Fees. Except for Goldman,
Sachs & Co. and McKinsey and Co., whose fees will be paid by Seller,
there is no investment banker, broker, finder or other
intermediary which has been retained by or is authorized to
74
act on behalf of Seller or Sterling who might be entitled to
any fee or commission from Seller or Sterling in connection
with the transactions contemplated by this Agreement.
Section 3.19 Continuing Service and Supply
Arrangements. The obligations of Sterling with respect to
continuing service and supply arrangements arising pursuant
to the Ethical Asset Purchase Agreement other than the Dudley
Supply Agreement (as defined in the Ethical Asset Purchase
Agreement) and the L&F Purchase Agreement, will have initial terms
that will not exceed three years. The Dudley Supply Agreement
will have an initial term that will not exceed five years. The
continuing service and supply arrangements arising pursuant to
the Ethical Asset Purchase Agreement and the L&F Purchase Agreement
will provide for charges associated with such arrangements to
be based on fully allocated costs plus a mark up of 3%.
Section 3.20 Insurance. Schedule 3.20 is a true
and complete list of all insurance policies that relate to the
Continuing Business (the "Policies"). Such insurance is
consistent with industry practice. No notice of cancellation
or termination has been received with respect to any of the
Policies. The Policies are in full force and will remain in
effect through the Closing Date. No proceeding is pending or,
to the knowledge of the Seller, threatened, to revoke, cancel
or limit any material Policy and no notice of cancellation of
any of such Policies has been
received.
75
Section 3.21 No Undisclosed Liability. Except as
reflected in the Financial Statements (including the notes
thereto) and except with respect to any item which is
otherwise disclosed as a liability in this Agreement or is
the subject of another representation or warranty in this
Article III or is the subject of an indemnity given by Seller
in favor of purchaser under Article VII, there are no
liabilities (absolute, accrued, contingent or otherwise) of
the Continuing Business that exceed, individually, $1,000,000
and are in the aggregate material, except liabilities that are
not material and were incurred since the date of the Balance
Sheet in the ordinary course of business consistent with past
practice.
Section 3.22 Environmental Matters.
(a) Other than with respect to the OTC Portion
during the Pre-Alliance Period and other than with respect to
items included on Schedule 7.3(a)(i):
(i) to the knowledge of Seller, the Continuing
Business is in compliance with all applicable Environmental
Laws and there are no material liabilities under any Environ-
mental Law with respect to the Continuing Business, other than
such non-compliance or liabilities which, individually or in
the aggregate, would not materially adversely affect
Sterling's ability to conduct the Continuing Business substan-
tially as heretofore conducted;
(ii) Seller, Sterling and the Subsidiaries have not
received, with respect to the Continuing Business, any notice
76
of any material violation or alleged material violation of, or
any material liability under, any Environmental Law affecting
the Continuing Business during the past three years;
(iii) there are no material writs, injunctions,
decrees, orders or judgments outstanding, or any actions,
suits, proceedings or investigations pending or, to the know-
ledge of Seller, threatened, relating to compliance by the
Continuing Business with or liability of the Continuing
Business under any Environmental Law affecting the Continuing
Business; and
(iv) to the knowledge of Seller, there are no
environmental liens affecting the Continuing Business, except
for such liens as would not, individually or in the aggregate,
materially adversely affect Sterling's ability to conduct the
Continuing Business substantially as heretofore conducted.
(b) With respect to the OTC Portion during the Pre-
Alliance Period, Seller repeats and confirms for the benefit
of Purchaser the representations and warranties made by Sanofi
to Seller and Sterling set out in Section 4.11 of the Ethical
Asset Purchase Agreement (a copy of which provision is
attached as Schedule 3.22(b) hereto).
Section 3.23 Other Information. The information
furnished by Seller in this Agreement, the Schedules identi-
fied herein and in any Certificate executed or delivered
pursuant hereto by or on behalf of the Seller is not
materially false or misleading and does not contain a
77
misstatement of a material fact or omit to state any material
fact required to be stated in order to make the statements
herein and therein not misleading.
Section 3.24 No Other Representations or Warran-
ties. Except for the representations and warranties contained
in this Article III, neither Seller nor any other Person makes
any other express or implied representation or warranty on
behalf of Seller or otherwise in respect of Sterling or the
Continuing Business.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF PURCHASER
Purchaser represents and warrants to Seller as of
the date hereof and as of the Closing Date (except that
representations and warranties that are made as of a
specific date need be true only as of such date) as follows:
Section 4.1 Organization and Qualification. Pur-
chaser is a corporation duly organized, validly existing and
in good standing under the laws of the jurisdiction of its
incorporation.
Section 4.2 Binding Effect. This Agreement con-
stitutes a valid and legally binding obligation of Purchaser
enforceable against Purchaser in accordance with its terms,
subject to bankruptcy, insolvency, reorganization, moratorium
and similar laws of general applicability relating to or
affecting creditors' rights and to general equity
principles.
78
Section 4.3 Corporate Authorization. Purchaser has
full corporate power and authority to execute and deliver this
Agreement, and to perform its obligations hereunder. The
execution, delivery and performance by Purchaser of this
Agreement has been duly and validly authorized by Purchaser
and, subject to obtaining the approval of the Board of Direc-
tors of Purchaser, no other corporate proceedings on the part
of Purchaser are required in connection with the execution,
delivery and performance by Purchaser of this Agreement.
Section 4.4 Consents and Approvals. Except as spe-
cifically set forth in Schedule 4.4 or as required by
Competition Laws, foreign investment laws, the laws governing
or regulations promulgated by the United States Drug
Enforcement Agency, and Bureau of Alcohol and Tobacco of the
United States Department of the Treasury and laws requiring
registration of products for sale, no consent, approval,
waiver or authorization is required to be obtained by
Purchaser from, and no notice or filing is required to be
given by Purchaser to or made by Purchaser with, any Govern-
mental Entity or other Person in connection with the
execution, delivery and performance by Purchaser of this
Agreement, other than in all those cases where the failure to
have or make such consent, approval, waiver, authorization,
notice or filing is not
material.
79
Section 4.5 Non-Contravention. Except as set forth
in Schedule 4.5, the execution, delivery and performance by
Purchaser of this Agreement, and the consummation of the
transactions contemplated hereby and thereby, does not and
will not (i) violate any provision of the Certificate of
Incorporation, Bylaws or other organizational documents of
Purchaser, (ii) subject as to performance to obtaining the
consents referred to in Section 4.4, conflict with, or result
in the breach of, or constitute a default under, or result in
the termination, cancellation or acceleration (whether after
the giving of notice or the lapse of time or both) of any
right or obligation of Purchaser under, or to a loss of any
benefit to which Purchaser is entitled under, any Contract or
other instrument to which Purchaser or any of its
subsidiaries is a party, or (iii) assuming as to
performance compliance with the matters set forth in
Sections 3.6 and 4.4, to the knowledge of Purchaser,
violate or result in a breach of or constitute a default
under any law, rule, regulation, judg- ment, injunction,
order, decree or other restriction of any court or
governmental authority to which Purchaser is subject,
including any Governmental Authorization, other than in the
cases of clauses (ii) and (iii), any conflict, breach,
termination, default, cancellation, acceleration, loss or
violation which, individually or in the aggregate, would not
be
material.
80
Section 4.6 Finders' Fees. Except for Wasserstein,
Perella & Co., whose fees will be paid by Purchaser, there is no
investment banker, broker, finder or other intermediary
which has been retained by or is authorized to act on
behalf of Purchaser who might be entitled to any fee or
commission from Purchaser in connection with the
transactions contem- plated by this Agreement.
Section 4.7 Financial Capability. On the Closing
Date, Purchaser will have sufficient funds to purchase the
Shares on the terms and conditions contemplated by this
Agree- ment.
Section 4.8 Securities Act. Purchaser is acquiring
the Shares solely for the purpose of investment and not
with a view to, or for sale in connection with, any
distribution thereof in violation of the Securities Act.
Purchaser acknowledges that the Shares are not registered
under the Securities Act or any applicable state securities
law, and that such Shares may not be transferred or sold
except pursuant to the registration provisions of such
Securities Act or pursuant to an applicable exemption
therefrom and pursuant to state securities laws and
regulations as applicable.
Section 4.9 No Other Representations or Warranties.
Except for the representations and warranties contained in
this Article IV, neither Purchaser nor any other Person makes
any other express or implied representation or warranty on
behalf of
Purchaser.
81
ARTICLE V
COVENANTS
Section 5.1 Access.
(a) Prior to the Closing, Seller shall permit
Purchaser and its representatives (and assignees of Purchaser
pursuant to Section 9.3 hereof) to have access, during regular
business hours and upon reasonable advance notice, to the
assets, employees, books and records of Sterling relating to
the Continuing Business and any assets or liabilities related
to any portion of the Transferred Businesses not reasonably
expected to be transferred prior to the Closing Date, subject
to reasonable rules and regulations of Seller, and shall
furnish, or cause to be furnished, to Purchaser, such
financial, tax (including available tax basis and earnings and
profits calculations) and operating data and other information
that is available with respect to the Continuing Business and
any such assets or liabilities as Purchaser shall from time to
time reasonably request.
(b) In the event of the termination of this Agree-
ment, Purchaser shall promptly deliver (without retaining any
copies thereof) to Seller, or (at Seller's option) certify to
Seller that it has destroyed, all documents, work papers and
other material obtained by Purchaser or on its behalf from
Seller, Sterling, any of the Subsidiaries, or any of their
respective agents, employees or representatives as a result
hereof or in connection herewith, whether so obtained before
82
or after the execution hereof. Purchaser shall at all times
prior to the Closing Date, and in the event of termination of
this Agreement, cause any information so obtained to be kept
confidential and will not use, or permit the use of, such
documents, work papers and other materials in its business or
in any other manner or for any other purpose except as
contemplated hereby. The foregoing shall not preclude
Purchaser from (i) the use or disclosure of such information
which currently is known generally to the public or which
subsequently has come into the public domain, other than by
way of disclosure in violation of this Agreement, (ii) the
use or disclosure of such information that becomes available
to Purchaser on a non-confidential basis from a source other
than Seller or Seller's agents provided that such source is
not known by Purchaser to have a legal obligation prohibiting
the disclosure of such information, or (iii) the disclosure
of such information required by law or court order,
provided that, to the extent practicable, prior to such
disclosure required by law or court order Purchaser will
give Seller prior written notice of the nature of the law
or order requiring disclosure and the disclosure to be made
in accordance therewith.
(c) From and after the date hereof, Seller shall
keep, shall cause its Affiliates to keep, and shall use
reasonable efforts to cause its officers, directors,
employees and agents to keep, confidential all information
proprietary
83
to the Continuing Business that has been acquired by Seller,
through its ownership and management of Sterling provided that
the foregoing restriction shall not apply to information that
(i) is or hereafter becomes generally available to the public
other than by reason of any default with respect to
confidentiality under this Agreement, (ii) was included in the
Confidential Memorandum -- Sterling Health (including
annexes), dated May, 1994, prepared by Goldman, Sachs & Co., or the
Sterling Health Management Presentation Book dated June 21,
1994, (iii) is hereafter disclosed to Seller by a third party
who is not in default of any confidentiality obligation to
Purchaser, (iv) is hereafter developed by or on behalf of
Seller, without reliance on confidential information acquired
prior to the date hereof through the ownership and management
of Sterling, (v) is reasonably required or desirable to be
submitted by Seller to governmental agencies, provided that
reasonable measures shall be taken to assure confidential
treatment of such information, (vi) is provided by Seller
under appropriate terms and conditions, including
confidentiality provisions equivalent to those in this
Agreement, (X) to third parties for consulting, accounting,
legal and similar purposes, or (Y) to prospective purchasers
of Seller or of all or any portion of the Transferred
Businesses to the extent considered reasonably necessary by
Seller to facilitate such purchase, (vii) Seller considers
reasonably necessary to disclose in connection with any
84
action, suit or proceeding before any court or any
governmental or other regulatory agency or body or any
arbitral panel, or any audit or investigation brought by any
governmental or other regulatory agency or body, (viii)
Seller considers reasonably necessary to disclose in order to
assert any claim against any insurer or other third party,
(ix) Seller considers reasonably necessary to disclose in
connection with the performance of its obligations under this
Agreement and the consummation of the transactions
contemplated hereby or (x) is required to be disclosed in
compliance with applicable laws or regulations or order by a
court or other governmental or regulatory agency or body
having competent jurisdiction. It is understood for purposes
of the foregoing that Seller will undertake reasonable
efforts to cause the employees of Sterling to comply with the
confidentiality provisions set forth in this Section 5.1(c)
but that any breach of this Section 5.1(c) by an employee of
Sterling shall be deemed not to be a breach by Seller of its
obligations hereunder.
Section 5.2 Conduct of Business. During the period
from the date hereof to the Closing, except (i) as otherwise
contemplated by this Agreement, (ii) as reasonably necessary
in connection with the Restructuring, or (iii) as Purchaser
shall otherwise agree in writing in advance, Seller covenants
and agrees that it shall cause Sterling to operate the
Continuing Business in the ordinary and usual course
85
consistent with past practice, and use its reasonable
efforts to preserve intact, to the extent constituting part
of the Continuing Business, its business and relationships
with customers, suppliers and other third parties. During the
period from the date hereof to the Closing, except (i) as
otherwise contemplated by this Agreement, (ii) as reasonably
necessary in connection with the Restructuring, or (iii) as
Purchaser shall otherwise consent (which consent shall not be
unreasonably withheld), Seller covenants and agrees that it
shall, with respect to the Continuing Business, cause
Sterling and the Subsidiaries to:
(i) maintain insurance coverage at presently
existing levels so long as such insurance is available at
commercially reasonable rates;
(ii) not approve any new individual capital
expenditure in excess of $1,000,000;
(iii) not dispose of or incur, create or assume
any Encumbrance other than Permitted Encumbrances on any
individual capital asset if the greater of the book value
or the fair market value of such capital asset exceeds
$1,000,000;
(iv) not (A) incur any indebtedness for money
borrowed in excess of $1,000,000 in the aggregate other
than any indebtedness incurred in the ordinary course of
business to refinance existing indebtedness on reasonable
terms not materially less advantageous to the Continuing
86
Business in the aggregate than the terms of the indebtedness
being refinanced and (B) assume, guarantee or endorse the
obligations of any person other than a Subsidiary or an
employee pursuant to a relocation policy;
(v) not enter into any material transaction or
amend any material term of, or waive any substantial
right under, any material Contract;
(vi) not effectuate (a) a "plant closing" as
defined in the WARN Act affecting any site of employment
or one or more facilities or operating units within any
site of employment or facility of the Continuing Business
or (b) a "mass layoff" as defined in the WARN Act
affecting any site of employment or one or more
facilities or operating units within any site of
employment or facilities of the Continuing Business,
except, in either case, after complying fully with the
notice and other requirements of the WARN Act;
(vii) not change or amend its charter or by-
laws, other than to change the names of Sterling or any
of the Subsidiaries; provided, that no such name change
shall involve the deletion of the word "Sterling";
(viii) not issue, sell, pledge, transfer,
repurchase or redeem or propose to issue, sell, pledge,
transfer, repurchase or redeem any shares of its capital
stock, or securities convertible into or exchangeable or
87
exercisable for, or options with respect to, or warrants to
purchase or rights to subscribe for, any shares of its capital
stock;
(ix) not declare or set aside for payment any
dividends to be paid after the Closing;
(x) not enter into any other agreements,
commitments or contracts which, individually or in the
aggregate, are material to the Continuing Business,
except agreements, commitments or contracts for the
purchase or sale of goods or services in the ordinary
course of business, consistent with past practice and not
in excess of current requirements;
(xi) not transfer or otherwise dispose of any
substantial assets of the Continuing Business other than
sales of inventory in the ordinary course of business
consistent with past practice;
(xii) except as required by law or regulation,
pursuant to existing agreements or as may be reasonably
necessary to secure or protect intellectual or industrial
property rights of the Continuing Business, not provide
any confidential or proprietary information with respect
to the Continuing Business to any Person other than
Purchaser, Seller or their respective Affiliates;
(xiii) not take any action which could be
reasonably expected to prevent or materially delay the
88
consummation of the transactions contemplated by this
Agreement;
(xiv) not change any of the accounting
principles or practices applied with respect to the
Continuing Business;
(xv) not enter into, adopt, amend (except as
required by applicable law or any existing contract, with
notice to the Purchaser) or terminate any Plan or
increase the amount or accelerate the payment or vesting
of any benefit payable thereunder, in each case in any
way that materially increases the amount of the liability
attributable to the Continuing Business in respect of
such Plan, or grant any material increases in the
compensation or fringe benefits of employees of the
Continuing Business; and
(xvi) not agree to take any of the foregoing
actions.
Notwithstanding the foregoing, but subject to clause
(ix) above, Sterling shall be permitted at all times prior to
the Closing Date to make distributions of cash to Seller.
Section 5.3 Best Efforts; Good Faith; Cooperation
in Restructuring.
(a) Seller and Purchaser will cooperate and use
their mutual best efforts to fulfill the conditions precedent
to the other party's obligations hereunder, including but not
limited to, securing as promptly as practicable all consents,
89
approvals, waivers and authorizations required in connection
with the transactions contemplated hereby and further
including taking all reasonable steps to consummate the
Closing (as defined in Section 1.1 of the Ethical Asset
Purchase Agreement). Purchaser and Seller will promptly file
documentary materials required by the Competition Laws,
Environmental Laws and each of the other items referred to in
Section 3.6 and Section 4.4 (whether or not material) and
promptly file any additional information requested as soon as
practicable after receipt of request thereof.
(b) Without limiting the provisions set forth in
paragraph (a) above, Purchaser shall use its best efforts to
take or cause to be taken all actions necessary, proper or
advisable to obtain any consent, waiver, approval or
authorization relating to any Competition Law that is
required for the consummation of the transactions contemplated
by this Agreement, which efforts shall include, without
limitation,
the proffer by Purchaser of its willingness to accept an order
providing for the divestiture by Purchaser of such of the
assets of the Continuing Business (or, in lieu thereof, assets
and businesses of the Purchaser having an approximately
equivalent value), as are necessary for the Purchaser fully to
consummate the transactions contemplated by this Agreement,
and an offer to hold separate such assets and businesses
pending such divestiture. In the event that regulatory
authorities require the divestiture and the holding separate
90
by Purchaser following the Closing of any of the assets or
entities of the Continuing Business, no adjustment shall be
made to the Purchase Price and Purchaser shall be required to
hold such assets or entities separate and divest them
following the Closing.
(c) Seller shall, and shall cause each of its
Affiliates (other than Sterling and the Subsidiaries) to, pay
all amounts from time to time payable to Sterling or its
Subsidiaries within 30 days after such payable arises (it
being understood that such obligation shall not apply with
respect to any such payable arising after Closing). Seller
shall cause Sterling and its Subsidiaries to pay all amounts
from time to time payable to Seller and its Affiliates within
30 days after such payable arises (it being understood that
such obligation shall not apply with respect to any such
payable arising after Closing).
(d) Seller will cooperate with Purchaser in
attempting to structure the sale of the Continuing Business
to Purchaser in a manner that would enable the Purchaser to
sell a portion of the Continuing Business to one or more
third parties; provided that such structure does not result
in economic detriment (including additional tax costs) to
Seller.
(e) If the Closing (as defined in Section 1.1 of
the Ethical Asset Purchase Agreement) of the transactions
under the Ethical Asset Purchase Agreement shall not have
occurred prior to the Closing Date, then immediately prior
to
91
the Closing Date, Seller shall cause the transfer of such
portions of the Ethical Transferred Business that would have
been transferred had such Closing (as defined in Section 1.1
of the Ethical Asset Purchase Agreement) occurred.
Section 5.4 Tax Matters.
(a) Tax Treatment. Seller and Purchaser agree that
an election under Section 338 of the Code (or any similar
provision of the law of any country or taxing jurisdiction)
will not be made with respect to the sale of the Shares
pursuant to this Agreement.
(b) Indemnification.
(i) Seller's Indemnification of Purchaser. Seller
shall indemnify the Purchaser Indemnified Parties from,
against and in respect of (A) any Taxes (including Transfer
Taxes) imposed in connection with or arising directly from
the Restructuring or the Transferred Businesses whether
arising with respect to a period before or after the Closing
Date, (B) except to the extent reflected as Current
Liabilities on the Adjusted Closing Balance Sheet and except
to the extent such Taxes are incurred solely as a result of
Purchaser's failure to comply with Section 5.4(i)(i), any
Taxes (including any Taxes imposed pursuant to Treas. Regs.
1502-6 or a similar provision of any state, local or foreign
income tax law imposing several liability upon the members of
a consolidated, combined, affiliated or unitary group) imposed
on Sterling or the Subsidiaries with respect to the taxable
periods, or
92
portions thereof, ending on or before the Closing Date; and
(C) any Transfer Taxes for which Seller is liable pursuant to
Section 5.4(g) hereof.
(ii) Purchaser's Indemnification of Seller.
Purchaser shall indemnify the Seller Indemnified Parties
from, against and in respect of any liability of Seller for
(A) any Taxes reflected as Current Liabilities on the Adjusted
Closing Balance Sheet, (B) any Taxes imposed with respect to
Sterling, the Subsidiaries or the Continuing Business for the
taxable periods, or portions thereof, beginning after the
Closing Date except to the extent that such Taxes (including
any Transfer Taxes) are imposed in connection with or arising
directly from the Restructuring or the Transferred Businesses;
(C) any Taxes incurred by any Seller Indemnified Party solely
as a result of Purchaser's failure to comply with Section
5.4(i)(i); and (D) any Transfer Taxes for which Purchaser is
liable pursuant to Section 5.4(g) hereof.
(iii) For purposes of this Section 5.4(b), the term
Taxes shall include Losses directly or indirectly relating to
or arising out of any liability for Taxes.
(c) Computation of Tax Liabilities.
(i) Proration of Taxes and Earnings and Profits. To
the extent permitted by law or administrative practice, the
taxable years of Sterling and each Subsidiary shall end on and
include the Closing Date. Whenever it is necessary to
determine the liability for Taxes, or the earnings and
93
profits, of Sterling or any Subsidiary for a portion of a
taxable year or period that begins before and ends after the
Closing Date, the determination of the Taxes or the earnings
and profits for the portion of the year or period ending on,
and the portion of the year or period beginning after, the
Closing Date shall be determined by assuming that the taxable
year or period ended on and included the Closing Date, except
that exemptions, allowances or deductions that are calculated
on an annual basis and annual property taxes shall be prorated
on the basis of the number of days in the annual period
elapsed through the Closing Date as compared to the number of
days in the annual period elapsing after the Closing Date.
(ii) Standalone Basis. Whenever it is necessary to
determine the liability of Sterling and the Subsidiaries for
Taxes, such liability shall be computed as if Sterling and
the Subsidiaries were not members of Seller's affiliated,
combined or unitary group for Tax purposes.
(d) Tax Returns.
(i) Seller shall prepare, or cause to be prepared,
and file or cause to be filed when due (A) all Tax Returns for
Sterling or the Subsidiaries due to be filed on or prior to
the Closing Date and (B) all Tax Returns for Sterling or the
Subsidiaries with respect to U.S. Federal, state and local
income taxes imposed with respect to the taxable periods, or
portions thereof, beginning before and ending on the Closing
Date which are required or permitted by law or
administrative
94
practice to be filed with respect to a taxable period, or
portion thereof, beginning before and ending on the Closing
Date.
(ii) Purchaser shall prepare, or cause to be
prepared, and file or cause to be filed when due all other Tax
Returns with respect to the Continuing Business due to be
filed after the Closing Date.
(iii) If either Purchaser or Seller may be liable
for any material portion of the Tax payable in connection with
any Tax Return to be filed by the other, the party responsible
for filing such return (the "Preparer") shall prepare and
deliver to the other party (the "Payor") a copy of such return
and any schedules, work papers and other documentation then
available that are relevant to the preparation of the portion
of such return for which the Payor is or may be liable
hereunder not later than 60 days before the Due Date. The
Preparer shall not file such return until the earlier of
either the receipt of written notice from the Payor indicating
the Payor's consent thereto, or the Due Date.
The Payor shall have the option of providing to the
Preparer, at any time at least 30 days prior to the Due Date,
written instructions as to how the Payor wants any, or all, of
the items for which it may be liable reflected on such Tax
Return. Failure by the Payor to give such written notice at
least 30 days prior to the Due Date shall constitute a waiver
by the Payor of its right to provide
instructions.
95
The Preparer shall, in preparing such return, cause
the items for which the Payor is liable hereunder to be
reflected in accordance with the Payor's instructions and, in
the absence of having received such instructions, in
accordance with past practice, subject in each case to the
Preparer's consent thereto.
A party may withhold its consent only if such party
believes that the manner of reporting of an item on the
return adversely affects that party. With respect to any Tax
Return covering the taxable period beginning before and ending
after the Closing Date the parties agree that the Purchaser
shall
not fail to consent to reflecting on such return all items for
which the Seller is liable on a basis which is consistent with
past practice. With respect to any Tax Return, the Purchaser
shall not object to any item which relates to the allocation
of purchase price with respect to any Restructuring
transaction and is in accordance with a written agreement
entered into by Seller or Sterling, or both.
If the Preparer refuses to consent to preparing the
return as instructed by the Payor or the Payor refuses to
consent to the return as prepared by the Preparer, or both,
the parties shall cooperate in good faith in attempting to
resolve their disagreement and prepare a return which both
parties consent to. If the disagreement has not been
resolved at least 20 days before the Due Date, the dispute
shall be referred to the CPA Firm which shall determine, with
respect
96
to each disputed item: (1) which party (the "Prevailing
Party") is advocating the more reasonable legal position for
reporting that item (the "Prevailing Position") and (2) if
requested, which party's estimate of the present value of the
cost the Prevailing Party will incur as a result of taking
the position (the "Non-Prevailing Position") put forth by
the other party (the "Non-Prevailing Party") is more
reasonable (the "Reasonable Cost").
After the dispute has been resolved, each disputed
item shall be recorded, if the dispute is resolved prior to
the Due Date, on the initial return which is filed by the
Preparer, or if the dispute is resolved after the Due Date,
on an amended return (if at the time the dispute is resolved
the return has already been filed and it is still possible at
that time to file an amended return) in accordance with (A)
the Prevailing Position or (B) if the Non-Prevailing Party
agrees to pay to the Prevailing Party the Reasonable Cost, the
Non- Prevailing Position.
If the dispute has not been resolved or the CPA Firm
has not made its determination prior to the Due Date, (1) each
disputed item shall be reported on the return that is filed by
the Preparer on the Due Date in accordance with the Preparer's
position (modified to the extent necessary to incorporate any
changes the parties have agreed upon) and (2) the Payor shall
pay to the Preparer the amount for which the Payor would be
liable if the return was filed as instructed by the Payor
97
(modified to the extent necessary to incorporate any changes
the parties have agreed upon) (the "Requested Amount"). When
the amount due to the Preparer from the Payor in respect of
such Tax Return is finally determined, a settlement payment
shall be made in an amount equal to the amount finally
determined to be due minus the Requested Amount plus interest
on such difference at the Prime Rate calculated from the Due
Date.
If the Preparer fails to satisfy its obligations
pursuant to this Section 5.4(d), the Payor shall have no
obligation to indemnify the Preparer for any Taxes which are
reflected on any such return or any related Loss, and shall
retain any and all remedies it may otherwise have which arise
out of such failure.
(e) Information to be Provided by Purchaser.
(i) With respect to Tax Returns to be filed by
Seller pursuant to Section 5.4(d) hereof, Purchaser shall,
within 60 days following the end of the taxable year
beginning before and ending on or after the Closing Date,
prepare and provide to Seller a package of tax information
materials (the "Tax Package"), which shall be completed in
accordance with the past practice of Sterling and any
Subsidiary included on any such returns, including past
practice as to providing the information, schedules, work
papers and other documentation, as to the method of
computation of separate taxable income or other relevant
measures of income and as to the calculation
98
and claiming of foreign tax credits. Purchaser shall cause the
Tax Package for the portion of the taxable period ending on
the Closing Date to be delivered to Seller within 60 days
after the Closing Date.
(ii) Foreign Tax Receipts. To the extent not con-
tained in the Tax Package, Purchaser shall to the extent
possible promptly, after receipt, deliver or cause to be
delivered to the tax director of Seller certified copies of
all receipts for foreign Taxes with respect to any taxable
period, or portion thereof, ending on or before the Closing
Date, and any other documentation required in connection with
Seller or its Affiliates claiming or supporting a claim for
foreign tax credits in connection with such foreign Taxes. In
addition, Purchaser, upon request of Seller's tax director,
agrees to request and obtain, at Seller's expense, for Seller
from local tax authorities receipts for foreign Taxes which
have not been provided to Seller or Purchaser.
(f) Contest Provisions.
(i) Notification of Contests. Each of Purchaser and
its Affiliates, on the one hand, and Seller, on the other
hand (the "Recipient"), shall notify the tax director of the
other party in writing within 30 days of receipt by the
Recipient of written notice of any pending or threatened
audits, adjustments or assessments (a "Tax Audit") which
may affect the liability for Taxes of such other party. If
the Recipient fails to give such prompt notice to the other
party it shall
99
not be entitled to indemnification for any Taxes arising in
connection with such Tax Audit if such failure to give notice
materially adversely affects the other party's right to
participate in the Tax Audit.
(ii) Which Party Controls. (A) Seller's Items. If
such Tax Audit relates to any period ending on or prior to the
Closing or for any Taxes for which Seller is liable in full
hereunder, Seller shall at its expense control the defense and
settlement of such Tax Audit.
(B) Purchaser's Items. If such Tax Audit relates to
any period beginning after the Closing or for any Taxes for
which Purchaser is liable in full hereunder, Purchaser shall
at its expense control the defense and settlement of such Tax
Audit.
(C) Combined and Mixed Items. If such Tax Audit
relates to Taxes for which both Seller and Purchaser are
liable hereunder, to the extent possible such Tax Items will
be distinguished and each party will control the defense and
settlement of those Taxes for which it is so liable.
If such Tax Audit relates to a taxable period, or
portion thereof, beginning before and ending after the
Closing Date and any Tax Item can not be identified as being a
liability of only one party or cannot be separated from a Tax
Item for which the other party is liable, the party which has
the greater potential liability for those Tax Items that
cannot be so attributed or separated (or both) shall control
100
the defense and settlement of the Tax Audit, provided that
such party defends the items as reported on the relevant Tax
Return. In defending the item as reported on the relevant
Tax Return, the party may negotiate any settlement that is
reasonable provided that it does not increase the liability of
the other party in an amount that is greater than such other
party's pro rata share of those items and does not trade any
item for which the other party has a greater liability for any
item for which it has a lesser liability, unless it obtains
the other's party consent thereto.
(D) Participation Rights. Any party whose liability
for Taxes may be affected by a Tax Audit shall be entitled to
participate at its expense in such defense and to employ
counsel of its choice at its expense.
(g) Transfer Taxes. All excise, sales, use, trans-
fer, (including real property transfer or gains), stamp,
documentary, filing, recordation and other similar taxes
together with any interest, additions or penalties with
respect thereto and any interest in respect of such additions
or penalties resulting directly from the sale and transfer by
Seller to Purchaser of the Shares (the "Transfer Taxes"),
shall be borne equally by Seller and Purchaser. Any such
Transfer Taxes or fees resulting from any transfer of all or
any portion of the Shares, the Investments or any asset
constituting part of the Continuing Business occurring on or
subsequent to the transfer of the Shares from Seller to
101
Purchaser contemplated hereby shall be borne entirely by the
Purchaser, and Purchaser shall indemnify Seller for any
liabilities arising in connection therewith. Notwithstanding
Section 5.4(d), which shall not apply to Tax Returns relating
to Transfer Taxes, any Tax Returns that must be filed in
connection with Transfer Taxes shall be prepared and filed
when due by the party primarily or customarily responsible
under the applicable local law for filing such Tax Returns,
and such party will use its reasonable efforts to provide
such Tax Returns to the other party at least 10 days prior to
the Due Date for such Tax Returns.
(h) Certain Post-Closing Settlement Payments.
(i) Purchaser's Claiming, Receiving or Using of
Refunds and Overpayments. If, after the Closing, Purchaser,
Sterling or any of their Affiliates (A) receive any refund, or
(B) utilize the benefit of any overpayment of Taxes (except to
the extent reflected on the Adjusted Closing Balance Sheet
as a Current Asset) which, in each case (A) and (B), (x)
relates to a Tax paid by Seller, Sterling or any Affiliate of
either of them prior to the Closing, or (y) is the subject of
indemnification by Seller pursuant to Article VII hereof,
Purchaser shall promptly transfer, or cause to be
transferred, to Seller the entire amount of the refund or
overpayment (including interest) received or utilized by
Purchaser, Sterling or any of their Affiliates net of
Purchaser's out-of- pocket costs of obtaining such refund
(including Taxes).
102
Purchaser agrees to notify Seller within a reasonable period
of time after the discovery of a right to claim any such
refund or overpayment and the receipt of any such refund or
utilization of any such overpayment. Purchaser agrees to
claim any such refund or to utilize any such overpayment as
soon as possible and to furnish to Seller all information,
records and assistance necessary to verify the amount of the
refund or overpayment.
(ii) Purchaser's Use of Tax Credits. Neither the
Purchaser nor any of its Affiliates shall be under any
obligation to make any payment to Seller for the use, after
the Closing, of any excess Tax credit (including any excess
foreign tax credit) or net operating loss of Sterling or any
Subsidiary of either of them existing as of the Closing Date,
and Seller shall not be liable to Purchaser for any change in
the amount of such credits or net operating loss after the
Closing Date which results from any adjustments made to any
Tax Return which affects the amount of such credits or net
operating loss.
(iii) Each Party's Claiming and Realizing of Tax
Benefits in Respect of Indemnified Liabilities. (A) If,
after the Closing, (a) Purchaser or any of its Affiliates
realizes any Loss for which it is indemnified by Seller
pursuant to Article VII hereof, or (b) an adjustment
required by any taxing authority in any item reflected on
a Tax Return increases Seller's liability for
indemnification payments
103
under this Agreement, Purchaser and its Affiliates agree to
claim any such Loss and recognize any such adjustment on their
Tax Returns to the extent such position is supported by
substantial authority and claim to the fullest extent possible
all deductions available as a result of any such Loss or
adjustment. Purchaser agrees to furnish to Seller at Seller's
expense all information, records and assistance necessary to
verify the amount of the decrease, if any, in Purchaser's and
its Affiliate's income taxes paid solely as a result of
recognizing such Loss or adjustment and claiming all such
available deductions (as compared to the income taxes
Purchaser and its Affiliates would otherwise have paid solely
without such adjustment). Purchaser shall promptly transfer,
or cause to be transferred, to Seller an amount equal to the
entire amount of such decrease (to the extent such decrease
has not been accounted for in the computation of the Loss
being indemnified for pursuant to Section 7.6 hereof) at the
time such decrease is realized, whether realized by Purchaser
and its Affiliates paying less income taxes or receiving a
refund.
(B) If, after the Closing, (a) Seller or any of its
Affiliates realizes any Loss for which it is indemnified by
Purchaser pursuant to Article VII hereof, or (b) an adjustment
required by any taxing authority in any item reflected on a
Tax Return increases Purchaser's liability for indemnification
payments under this Agreement, Seller and its Affiliates
agree
104
to claim any such Loss and recognize any such adjustment on
their Tax Returns to the extent such position is supported by
substantial authority and claim to the fullest extent possible
all deductions available as a result of any such Loss or
adjustment. Seller agrees to furnish to Purchaser at
Purchaser's expense all information, records and assistance
necessary to verify the amount of the decrease, if any, in
Seller's and its Affiliate's income taxes paid solely as a
result of recognizing such Loss or adjustment and claiming all
such available deductions (as compared to the income taxes
Seller and its Affiliates would otherwise have paid solely
without such adjustment). Seller shall promptly transfer, or
cause to be transferred, to Purchaser an amount equal to the
entire amount of such decrease (to the extent such decrease
has not been accounted for in the computation of the Loss
being indemnified for pursuant to Section 7.6 hereof) at the
time such decrease is realized, whether realized by Seller
and its Affiliates by paying less income taxes or receiving a
refund.
(C) In no event shall this Section 5.4(h)(iii)
relate to a taxable year ending after December 31, 2010;
provided, however, that at any time Seller and Purchaser may
negotiate a settlement pursuant to which all rights and
obligations under this Section 5.4(h)(iii) shall be
terminated.
105
(iv) Purchaser's Carryback of Post-Closing Deduc-
tions or Losses. If Sterling or the Subsidiaries are entitled
to carryback any net operating loss, capital loss, excess
foreign tax paid, or other similar losses, deductions or
credits derived with respect to any period beginning after the
Closing Date to any period prior to the Closing Date, and any
such carryback results in a decrease in Seller's income taxes
paid (as compared to the income taxes Seller would otherwise
have paid solely without giving effect to such carryback),
Seller shall pay to Purchaser the amount of such decrease at
the time such decrease is realized by refund or otherwise.
Seller shall take all necessary actions to claim any such
carryback and Purchaser shall indemnify Seller for its reason-
able out-of-pocket expenses incurred in reviewing and
responding to a request for its consent pursuant to this
Section 5.4(h)(iv), and in filing and securing any such
decrease.
(v) Methodology and Procedure.
(A) Ordering Rules. In determining, for the
purposes of any provision in this Section 5.4 or Section 7.6,
the amount of the decrease or increase in Taxes paid by a
party as a result of realizing or utilizing any Tax Item
such calculation shall be made by comparing the income taxes
paid by the party taking into account such Tax Item with the
income taxes the party would have paid had it not taken such
Tax Item into account. It is understood that in making such
106
calculation, any Tax Item that such party would have had in
the absence of the Tax Item whose effect is being determined,
shall be deemed to be recognized or used first, and that the
Tax Item whose effect is being determined shall be deemed to
be utilized last.
(B) Subsequent Adjustment. In the event that any
Tax refund, benefit or savings described in any clause of
this Section 5.4(h) is subsequently reduced as a result of any
adjustment required by any determination as defined in Section
1313 of the Code, this Section 5.4(h) shall be applied, taking
into account such adjustment. Additionally, if subsequent to
the application of any provision of this Agreement relating to
the effect of any Tax Item, any person generates any Tax Item
which could have been utilized in place of the Tax Item the
effect of which was previously determined to result in a Tax
benefit to such person, the provision of this Agreement
relating to the effect of such Tax Item shall be reapplied
taking into account such subsequently created Tax Item and the
parties shall make any additional payment or refund any
portion of any prior payment received necessary to settle the
difference between the amount previously paid and the amount
subsequently determined to be due.
(C) Resolution of All Tax Related Disputes. For
the purposes of computing the amount of any payment due
relating to the effect of any Tax Item, each party shall
provide to the other, as reasonably requested by the other,
107
all information, records and assistance necessary to verify
the relevant Tax effects. In the event that Seller and
Purchaser cannot agree on any calculation of any amount
relating to Taxes or the interpretation or application of any
provision of this Agreement relating to Taxes, such dispute
shall be resolved by the CPA Firm, whose decision shall be
final and binding upon all persons involved and whose
expenses shall be shared equally by Seller and Purchaser.
(i) Post-Closing Actions Which Affect Seller's
Liability for Taxes.
(i) Purchaser shall not permit Sterling or any
Subsidiary to take any action on the Closing Date which could
materially increase Seller's liability for Taxes
(including any liability of Seller to indemnify Purchaser
for Taxes pursuant to this Agreement).
(ii) Purchaser shall indemnify the Seller
Indemnified Parties for all Taxes resulting solely from any
distribution or any deemed distribution by Sterling or any
Subsidiary to its respective shareholders in excess of such
entity's current earnings and profits (as computed for U.S.
Federal income tax purposes and pursuant to Section
5.4(c)(i)) derived during the period beginning on the day
following the Closing Date and ending on the first December
31st thereafter if the Closing Date shall not be December 31
of any year.
(iii) Except to the extent required by law, neither
Purchaser, Sterling, nor any Affiliate of either of them
108
shall, without the prior written consent of Seller, amend any
Tax Return filed by, or with respect to, Sterling or any of
its Affiliates for any taxable period, or portion thereof,
beginning before the Closing Date.
(j) Post-Closing Actions which Affect Purchaser's
Liability for Taxes. Seller shall not reattribute any net
operating losses or similar items from Sterling or any
Subsidiary to Seller under Treas. Regs. 1.1502-20 or a similar
law of any other taxing jurisdiction without the prior written
consent of Purchaser.
(k) Maintenance of Books and Records. Until the
applicable statute of limitations (including periods of
waiver) has run for any Tax Returns filed or required to be
filed covering the periods up to and including the Closing
Date, Purchaser shall retain all Books and Records in
existence on the Closing Date and after the Closing Date will
provide Seller access to such Books and Records for
inspection and copying by Seller and its representatives
during normal business hours upon reasonable request and upon
reasonable notice. After the expiration of such period, no
such Books and Records shall be destroyed by Purchaser without
first advising the tax director of Seller in writing
detailing the contents of any such Books and Records and
giving Seller at least 120 days to obtain possession
thereof.
(l) Termination of Existing Tax Sharing Agreements.
Any and all existing Tax sharing agreements or arrangements,
109
written or unwritten, binding Sterling or any Subsidiary,
other than an agreement entered into in connection with the
Restructuring, shall be terminated as of the Closing.
(m) At or prior to Closing Seller shall deliver to
Purchaser a certificate of non-foreign status in compliance
with Section 1445 of the Code and applicable Treasury
Regulations.
(n) Assistance and Cooperation. The parties agree
that, after the Closing Date:
(A) Each party shall assist (and cause their
respective Affiliates to assist) the other party in
preparing any Tax Returns which such other party is
responsible for preparing and filing;
(B) The parties shall cooperate fully in preparing
for any audits of, or disputes with taxing authorities
regarding, any Tax Returns and payments in respect
thereof;
(C) The parties shall make available to each other
and to any taxing authority as reasonably requested all
relevant Books and Records relating to Taxes;
(D) Each party shall provide timely notice to the
other in writing of any pending or proposed audits or
assessments with respect to Taxes for which the other may
have an indemnification obligation under this Agreement;
(E) The parties shall furnish the other with copies
of all relevant correspondence received from any taxing
110
authority in connection with any audit or information request
with respect to any Taxes referred to in subsection (D) above;
and
(F) Except as otherwise provided herein, the party
requesting assistance or cooperation shall bear the other
party's out-of-pocket expenses in complying with such
request to the extent that those expenses are
attributable to fees and other costs of unaffiliated
third-party service providers.
(o) This Article V shall govern the procedure for
all Tax indemnification claims.
(p) Any reference in this Section 5.4 to Purchaser
and its Affiliates with respect to any time after the Closing
shall be deemed to include Sterling and the Subsidiaries.
Section 5.5 Post-Closing Obligations to Certain
Employees.
(a) Purchaser shall cause each of Sterling and the
Subsidiaries to continue the employment on the Closing Date,
in comparable positions, of all active Employees on such date
or upon the return to active employment of any Employee who
is, on such date, on disability or medical leave or on
Nonmedical Leave, and will maintain for a period of two years
after the Closing Date, without interruption, employee
compensation and benefit plans, programs and policies and
fringe benefits (including post-employment welfare benefits)
that, in the aggregate, will provide benefits to Employees
111
that are no less favorable than those provided pursuant to
such employee benefit plans, programs and policies, and fringe
benefits, of each of Sterling and the Subsidiaries as in
effect on the Closing Date. Notwithstanding the foregoing,
for a period of two years after the Closing Date, Purchaser
will cause each of Sterling and the Subsidiaries to maintain
severance programs which provide to each Employee severance
pay and benefits which are no less favorable than those under
the severance plan, program or policy of Sterling or the
Subsidiary applicable to such Employee as in effect on the
date of this Agreement. Employees shall be given credit for
all service with Sterling or any of the Subsidiaries or any
Affiliate of Sterling (or service credited by Sterling or any
of the Subsidiaries or Seller) to the same extent as such
service was credited for such purpose by Sterling or any of
the Subsidiaries or Seller, under (i) all employee benefit
plans, programs and policies, and fringe benefits of
Purchaser in which they become participants for purposes of
eligibility, vesting and benefit accrual and (ii) severance
plans for purposes of calculating the amount of each
Employee's severance benefits. Nothing in this Section 5.5(a)
shall be deemed to require the employment of any Employee to
be continued for any particular period of time after the
Closing Date.
(b) (i) Seller shall cause to be transferred from
the Eastman Kodak Employees' Savings and Investment Plan (the
112
"Seller Savings Plan") to the Sterling Winthrop Inc. Salaried
Employees' Savings Plan (the "Transferee Savings Plan") the
liability for the account balances of active Employees who
were participants in the Seller Savings Plan (the "Savings
Plan Employees"), together with assets which are reasonably
acceptable to the trustee of the Transferee Savings Plan and
the fair market value of which is equal to such liability,
and Purchaser shall cause the Transferee Savings Plan to
accept such transfer (the acceptance of the liability being
conditioned upon the asset transfer). The transfer of assets
shall take place within 90 days after the Closing Date;
provided, however, that in no event shall such transfer take
place until the later of (A) the furnishing to Seller by
Purchaser of a favorable determination letter from the
Internal Revenue Service with respect to the qualification of
the Transferee Savings Plan under Section 401(a) of the Code,
as amended to comply with changes to the qualification
requirements of Section 401(a) of the Code made by the Tax
Reform Act of 1986 and other recent legislation and
regulations, and (B) the receipt by Seller of a favorable
determination letter from the Internal Revenue Service with
respect to the continued qualification of the Seller Savings
Plan under Section 401(a) of the Code, as amended to comply
with changes to the qualification requirements of Sec-
tion 401(a) of the Code made by the Tax Reform Act of 1986 and
other recent legislation and
regulations.
113
(ii) Effective as of the Closing Date, Purchaser
shall establish (or, in Purchaser's discretion, designate) a
defined benefit plan (the "Transferee Pension Plan") for the
benefit of Employees who participated in the Kodak Retirement
Income Plan (the "Seller Retirement Plan"). Such Employees are
referred to hereinafter as the "Retirement Plan Employees".
The Transferee Pension Plan shall (A) recognize for all
purposes thereunder the service of the Retirement Plan
Employees which was recognized under the Seller Retirement
Plan and (B) provide, upon the transfer of assets referred to
below, that the benefit liabilities of the Retirement Plan
Employees under the Transferee Pension Plan shall in no event
be less than their benefit liabilities under the Seller
Retirement Plan as of the Closing Date.
Seller shall cause to be transferred from the trust
under the Seller Retirement Plan to the trust under the
Transferee Pension Plan assets in the form of cash, cash
equivalents and marketable securities (reasonably acceptable
to the trustee of the Transferee Pension Plan), the fair
market value of which shall be equal to the product of (x)
times (y), where (x) equals the fair market value of the
assets of the Seller Retirement Plan on the date of actual
transfer of assets from the trust thereunder to the trust
under the Transferee Pension Plan, and (y) equals a fraction,
the numerator of which is the present value of the benefit
liabilities on a termination basis of the Retirement Plan
114
Employees under the Seller Retirement Plan as of the effective
date of the transfer (the last day of the calendar month in
which the Closing Date occurs) and the denominator of which is
the present value of the benefit liabilities on a termination
basis of all participants in the Seller Retirement Plan as of
the effective date of the transfer (the last day of the
calendar month in which the Closing Date occurs); provided,
however, that the benefits of the Retirement Plan Employees
under the Seller Retirement Plan shall be calculated as if the
credited service for each Retirement Plan Employee continued
to accrue through the last day of the calendar month in which
the Closing Date occurs. Notwithstanding any other provision
hereof, such transfer of assets shall be made in compliance
with Section 414(l) of the Code. Purchaser shall cause the
Transferee Pension Plan to accept such transfer.
The amount to be transferred shall be equitably
adjusted to take into account non-investment receipts and
disbursements of the Seller Retirement Plan after the Closing
Date but prior to the date of transfer provided for in this
subparagraph, such as distributions, contributions and plan
to plan transfers.
The benefit liabilities under the Seller Retirement
Plan shall be valued as of the effective date of the transfer
(the last day of the calendar month in which the Closing Date
occurs), on the basis of the actuarial assumptions for the
Seller Retirement Plan as contained in the most recent
115
actuarial report for such Plan that is available as of the
date of this Agreement, as determined by the actuary for the
Seller Retirement Plan and reviewed by the actuary for the
Transferee Pension Plan.
The transfer of assets referred to above shall take
place within 180 days after the Closing Date; provided,
however, that in no event shall such transfer take place
until the last to occur of the following: (i) Purchaser has
furnished to Seller a favorable determination letter from the
Internal Revenue Service with respect to the qualification of
the Transferee Pension Plan under Section 401(a) of the Code,
as amended to comply with the changes to the qualification
requirements of Section 401(a) of the Code made by the Tax
Reform Act of 1986 and other recent legislation and
regulations, (ii) the receipt by Seller of a favorable
determination letter from the Internal Revenue Service with
respect to the continued qualification of the Seller
Retirement Plan under Section 401(a) of the Code, as amended
to (A) comply with changes to the qualification requirements
of Section 401(a) of the Code made by the Tax Reform Act of
1986 and other recent legislation and regulations and
(B) provide for the transfer of assets and benefit liabilities
referred to in this Section, and (iii) the receipt of any
other necessary governmental approval. Notwithstanding any
other provision of this Section 5.5, until the date of the
actual transfer of assets from the Seller Retirement Plan to
116
the Transferee Pension Plan, Purchaser and the Transferee
Pension Plan shall be entitled to offset (i) the benefit which
would otherwise be payable to an Employee by the Transferee
Pension Plan at the Employee's retirement or vested
termination of employment by (ii) the accrued benefit with
respect to such Employee under the Seller Retirement Plan
(the offset so calculated to apply without regard to the
benefit actually paid by the Seller Retirement Plan).
Notwithstanding anything contained in this Section
to the contrary, (A) in the event that the Internal Revenue
Service or any other governmental agency takes the position
in a determination letter, ruling, advisory opinion or other
written or oral communication that the transfer of assets
referred to in this Section cannot be made unless (i) addi-
tional contributions are made to the Seller Retirement Plans
or the Transferee Pension Plan or (ii) the Seller Retirement
Plan retains primary or secondary liability with respect to
the benefit liabilities under such Seller Retirement Plan
attributable to Retirement Plan Employees or (B) in the event
that a lawsuit is instituted by any of the foregoing or by
one or more participants in, or fiduciaries (other than Seller
or Purchaser) of, the Seller Retirement Plan or the Transferee
Pension Plan which seeks to enjoin such transfer, to require
additional contributions to the Seller Retirement Plan or the
Transferee Pension Plan, or to have the Seller Retirement Plan
remain liable in whole or in part with respect to any of the
117
benefit liabilities under such Seller Retirement Plan attribu-
table to Retirement Plan Employees, then the transfer of
assets referred to in this Section from the Seller Retirement
Plan will not be made until the earliest of (I) the date the
issues raised by the Internal Revenue Service or any other
governmental agency or such lawsuit are resolved favorably,
and Seller and the Seller Retirement Plan shall make every
effort in good faith to carry out the asset transfer, includ-
ing, but not limited to, the vigorous defense of any lawsuit
described in clause (B), and the exhaustion of all rights of
available judicial review and appeal, or (II) the date Seller
and Purchaser enter into a written agreement to resolve on a
basis mutually satisfactory to them the issues raised by the
Internal Revenue Service or any other governmental agency or
such lawsuit.
(iii) Pending the completion of the transfers des-
cribed in this paragraph (b), Seller and Purchaser shall make
arrangements for any required payments to the Savings Plan
Employees and the Retirement Plan Employees from the Seller
Savings Plan and the Seller Retirement Plan. Seller and
Purchaser shall provide each other with access to information
reasonably necessary in order to carry out the provisions of
this paragraph. Seller and Purchaser shall each use their
best efforts to satisfy promptly the conditions for such
transfers and to implement such transfers as soon as
practicable.
118
(c) If Purchaser shall include the Employees and
their beneficiaries in Purchaser's medical, dental or health
plans, such plans shall waive any preexisting condition limi-
tations and shall, if such inclusion occurs in the calendar
year which includes the Closing Date, honor any deductible and
out of pocket expenses incurred by such Employees and their
beneficiaries under the medical, dental or health plans of
Seller and the Subsidiaries during the portion of the calendar
year preceding the Closing Date.
(d) Purchaser shall give Seller at least 90 days
advance written notice of any transfer of assets and liabili-
ties from the Sterling Winthrop Inc. Hourly Employees' Savings
Plan or the Sterling Products International Inc. Pension Plan
for Employees who are Employed at Facilities Located in Puerto
Rico (the "Puerto Rico Pension Plan") pursuant to Section
5.5(c) of the Ethical Purchase Agreement. At the time such
notice is given, Purchaser shall cause Sterling to provide
Seller with appropriate information in order to enable Seller
to verify the determination of the calculation of the assets
and liabilities to be transferred, including information
relating to such transfer which Sterling (or its
representatives) provides to Sanofi (or its representatives)
pursuant to the Ethical Purchase Agreement.
(e) Purchaser shall use its best efforts to provide
for transfers of assets and liabilities from (i) Sterling's
non-U.S. benefit plans to non-U.S. benefit plans for
employees
119
of the L&F Transferred Business in an equitable manner and (ii) the
Puerto Rico Pension Plan to a defined benefit plan for
employees of the L&F Transferred Business participating therein, in
an equitable manner.
Section 5.6 Compliance with WARN, etc. Purchaser
with respect to the Employees will timely give all notices
required to be given under WARN or other similar statutes or
regulations of any jurisdiction relating to any plant closing
or mass layoff or as otherwise required by any such statute.
Section 5.7 Notification of Certain Matters. Seller
shall give prompt notice to Purchaser and Purchaser shall give
prompt notice to Seller of the occurrence, or non-occurrence,
of any event the occurrence or non-occurrence of which
would be reasonably likely to cause (i) any representation
or warranty of Seller or Purchaser, as the case may be,
contained in this Agreement to be untrue or inaccurate in any
material respect at or prior to the Closing as the case may
be, or (ii) Seller or Purchaser, as the case may be, to
fail to comply with or satisfy any covenant, condition or
agreement to be complied with or satisfied by it hereunder;
provided, however, that the delivery of any notice pursuant to
this Section 5.7 shall not limit or otherwise affect the
remedies available hereunder to the party receiving such
notice.
120
Section 5.8 License Agreements.
(a) At the Closing, Sterling and Seller shall
execute and deliver, and Seller shall cause any other
Affiliate of Seller necessary to the effectiveness of this
Section 5.8 to execute and deliver, an exclusive, non-
assignable (except in whole or in part to Affiliates of
Sterling or Purchaser or upon the sale by Sterling of a
substantial portion of the assets related to the license),
perpetual, worldwide, royalty-free license agreement pursuant
to which Seller will license to Sterling nanoparticulate
technology (including patents and patent applications) to the
extent necessary to permit Sterling to, and to hire others
(on terms reasonably satisfactory to Seller) to, develop,
manufacture and sell products containing naproxen as an over-
the-counter product; provided, however, that no representation
will be made that Seller's technology constitutes all the
technology necessary for the development, manufacture or sale
of such product. In addition to the terms stated above, the
other provisions of said licenses shall be those normal and
customary to similar licenses consistent with Seller's past
practices.
(b) At the Closing, Sterling and Seller shall
execute and deliver, and Seller shall cause any other
Affiliate of Seller necessary to the effectiveness of this
Section 5.8 to execute and deliver, a non-assignable (except
in whole or in part to Affiliates of Sterling or Purchaser
or
121
upon the sale by Sterling of a substantial portion of the
assets related to the license), perpetual, worldwide, royalty-
free license agreement pursuant to which Seller will license
to Sterling gelcap and geltab technology (including patents
and patent applications) to the extent necessary to permit
Sterling to, and to hire others (on terms reasonably
satisfactory to Seller) to, develop, manufacture and sell
human pharmaceutical products currently under development or
similar products for the same or similar indications to be
sold as part of the Continuing Business as over-the-counter
products; provided, however, that no representation will be
made that Seller's technology constitutes all the technology
necessary for the development, manufacture or sale of such
products. Such license shall be exclusive as to analgesics
that are over-the-counter human pharmaceutical products and
shall be non-exclusive as to other over-the-counter human
pharmaceutical products. In addition to the terms stated
above, the other provisions of said licenses shall be those
normal and customary to similar licenses consistent with
Seller's past practices.
Section 5.9 Certain Provisions Relating to the
Restructuring.
(a) Seller shall, to the extent reasonably
practicable, complete the Restructuring prior to the Closing.
Purchaser will cooperate with Seller and Sterling in carrying
out the Restructuring. If Seller becomes aware that any
122
portion of the Restructuring is not likely to be complete
prior to the Closing (including, without limitation, in the
event that assets and liabilities of Sterling constituting
part of the Transferred Businesses will not be sold,
assigned, transferred, conveyed or delivered prior to the
Closing), Seller shall attempt to identify such portion of the
Restructuring (and such assets and liabilities) and give
Purchaser notice thereof. In the event that portions of the
Restructuring are not complete prior to the Closing
(including, without limitation, in the event that assets and
liabilities of Sterling constituting part of the Transferred
Businesses have not been sold, assigned, transferred,
conveyed or delivered because a required authorization,
approval, consent or waiver has not been obtained), then (i)
Purchaser shall cause Sterling and the Subsidiaries, at
Seller's sole cost and expense, to comply with any provisions
of the Ethical Asset Purchase Agreement and any other
agreement to which Sterling or any of the Subsidiaries is a
party relating to holding, operating and transferring any such
assets and liabilities and performing any unperformed
obligations of Sterling or any such Subsidiary in connection
with such por- tions of the Restructuring as are not complete
and (ii) Pur- chaser shall cause Sterling and the Subsidiaries
to take such steps as directed in writing by Seller as are
necessary to permit Seller to complete the Restructuring in
the manner selected by Seller and to transfer to Seller (or
the Person
123
designated by Seller), without payment of further
consideration, any assets or cash received by Sterling or any
of the Subsidiaries in connection with the Restructuring.
(b) In the event that record ownership of any
assets or liabilities related to a portion of a Transferred
Business has not been transferred prior to the Closing,
Purchaser shall hold, solely of record and not beneficially,
the portion of such Transferred Business represented by such
assets and liabilities for the benefit of such Person as may
be designated by Seller, and Purchaser shall use its
reasonable best efforts, and shall cause Sterling and its
Affiliates to use their reasonable best efforts pending the
transfer of record ownership of the portion of such
Transferred Business represented by such assets and
liabilities, to provide to Seller's designee all of the
benefits and liabilities associated with the ownership and
operation of the portion of such Transferred Business
represented by such assets and liabilities and, accordingly,
Purchaser and Sterling shall cause the portion of such
Transferred Business represented by such assets and
liabilities to be operated as may reasonably be instructed by
Seller or its designee; provided, however, that Purchaser,
Sterling and their respective Affiliates shall not have any
liability to Seller or any other Person in respect of any
action taken with respect to such assets and liabilities in
accordance with such instructions. In performing its
124
obligations hereunder, neither Purchaser, nor Sterling, nor
any of their respective Affiliates shall be construed to be a
trustee or other fiduciary for the beneficial owner of such
portion of the Transferred Business.
(c) Purchaser acknowledges that, in connection with
the Restructuring, Seller and Sterling have entered into the
Ethical Asset Purchase Agreement, and that Seller, Sterling
and certain Affiliates of Sterling will enter into certain
other agreements relating to the Restructuring. Seller will
consult with Purchaser before entering into such other
agreements and will not agree to any terms which impose
material liabilities or obligations on Sterling or any of the
Subsidiaries following the Closing without Purchaser's
consent, which consent shall not be unreasonably withheld.
Purchaser's consent shall not be deemed to have been
reasonably withheld if Seller shall have agreed to fully
indemnify Purchaser against any Losses associated with such
liabilities or obligations and Purchaser believes in its
reasonable judgment that such indemnity is enforceable.
Purchaser agrees to cause Sterling and its Subsidiaries to
perform their obligations under the Ethical Asset Purchase
Agreement and such other agreements relating to the
Restructuring in accordance with their respective terms.
(d) Seller shall use its reasonable best efforts to
bring about the Closing (as defined in the Ethical Asset
Purchase Agreement) of the transfer of the Ethical
Transferred
125
Business by the end of the day on October 1, 1994 or as
promptly as practicable thereafter. Seller shall provide to
Purchaser for its review, and shall consult with Seller with
respect to, all schedules prepared identifying assets and
liabilities to be transferred pursuant to the Ethical Asset
Purchase Agreement.
(e) Prior to the Closing, Seller shall cause
Sterling to transfer the UPT Facility to Seller, an Affiliate
of Seller or any other Person designated by Seller.
(f) Prior to the Closing, Seller shall cause
Sterling either to transfer the Nanoparticulate Business Unit
to Seller, an Affiliate of Seller or any other Person
designated by Seller.
(g) Prior to the Closing, Seller shall cause
Sterling to transfer the L&F Transferred Business to Seller, an
Affiliate of Seller or any other Person designated by Seller.
Notwithstanding any provision to the contrary contained in
this Agreement and in furtherance of the provisions set forth
in paragraph (a) of this Section 5.9, Purchaser acknowledges
that record ownership of certain assets and liabilities
constituting part of the L&F Transferred Business may not be
transferred out of Sterling or its Subsidiaries prior to the
Closing. With respect to any such assets and liabilities,
Purchaser shall agree with Seller, the Affiliate of Seller or
such other Person, as the case may be,